| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | ABI3 SPTB SPTBN1 SPTBN2 SPTBN5 TLN2 PLEC MYO18B ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 SPTBN4 MACF1 | 1.57e-08 | 227 | 207 | 15 | GO:0051015 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | SPTB SPTBN1 SPTBN2 TLN2 PLEC ANK2 SYNM LMNB2 SPTBN4 INA CROCC | 1.13e-07 | 130 | 207 | 11 | GO:0005200 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABI3 SPTB SPTBN1 SPTBN2 CCDC88B TAOK2 SPTBN5 TLN2 DLG4 JAKMIP1 PLEC MYO18B TBCC ESPN ANK2 SYNM CAPZA1 CAPZA2 NUMA1 HIP1R MIB2 SHROOM2 SMTN SPTBN4 CCDC88C KIFAP3 MACF1 ARHGEF2 CROCC UNC13A | 1.16e-06 | 1099 | 207 | 30 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | ABI3 SPTB SPTBN1 SPTBN2 SPTBN5 TLN2 PLEC MYO18B ESPN CAPZA1 CAPZA2 HIP1R MIB2 SHROOM2 SMTN SPTBN4 MACF1 CROCC | 2.76e-06 | 479 | 207 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | structural molecule activity | EPPK1 SPTB SPTBN1 SPTBN2 EVPL TLN2 DLG4 MACROH2A2 PLEC ANK2 KRT18 SYNM NUMA1 LAMA2 LAMA4 LAMB2 LMNB2 SMTN SPTBN4 IGF1R INA NUP155 MACF1 CROCC | 1.87e-05 | 891 | 207 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | ankyrin binding | 8.51e-05 | 23 | 207 | 4 | GO:0030506 | |
| GeneOntologyMolecularFunction | kinesin binding | 2.60e-04 | 55 | 207 | 5 | GO:0019894 | |
| GeneOntologyMolecularFunction | spectrin binding | 4.08e-04 | 34 | 207 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 7.99e-04 | 18 | 207 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | protein domain specific binding | ABI3 KCNH2 PKD1 DLG4 GNAI3 ESPN LNX2 NRL NUMA1 HIP1R CHD8 GRIK5 SHROOM2 CIT CCDC88C CCT6A SKAP1 HGS UNC13A NOS1AP | 8.02e-04 | 875 | 207 | 20 | GO:0019904 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C TNF ARHGEF2 | 4.34e-10 | 100 | 210 | 12 | GO:0043242 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C ARHGEF2 | 1.71e-09 | 89 | 210 | 11 | GO:1901880 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 | 2.49e-09 | 52 | 210 | 9 | GO:0030835 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C IGF1R TNF ARHGEF2 | 2.84e-09 | 144 | 210 | 13 | GO:0043244 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C ARHGEF2 | 1.01e-08 | 105 | 210 | 11 | GO:1901879 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 | 1.09e-08 | 61 | 210 | 9 | GO:0030834 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 | 2.22e-08 | 66 | 210 | 9 | GO:0030042 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 NCKAP1L | 3.44e-08 | 177 | 210 | 13 | GO:0008064 |
| GeneOntologyBiologicalProcess | regulation of actin filament length | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 NCKAP1L | 4.20e-08 | 180 | 210 | 13 | GO:0030832 |
| GeneOntologyBiologicalProcess | actin filament-based process | HSP90B1 ABI3 SPTB SPTBN1 SPTBN2 TAOK2 SPTBN5 PIK3CA KCNH2 TLN2 PLEC AMOTL2 MYO18B ESPN ANK2 CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SMTN SPTBN4 CCDC88C NUP155 TENM1 TNF ARHGEF2 NOS1AP NCKAP1L | 5.35e-08 | 912 | 210 | 29 | GO:0030029 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 SPTBN4 CCDC88C ARHGEF2 | 1.02e-07 | 194 | 210 | 13 | GO:0051494 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TBC1D9B ABI3 SPTB SPTBN1 SPTBN2 DELE1 MAP3K4 TAOK2 SPTBN5 PHLDB1 PIK3CA PKD1 NCAPD2 SLC30A9 PML ESPN CAPZA1 CAPZA2 NUMA1 HIP1R GRIK5 SHROOM2 CIT PRMT6 SPTBN4 CCDC88C CCT6A VPS13D IGF1R TENM1 TNF ARHGEF2 CROCC SLX4 NCKAP1L | 2.57e-07 | 1342 | 210 | 35 | GO:0033043 |
| GeneOntologyBiologicalProcess | protein depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C ARHGEF2 | 2.69e-07 | 144 | 210 | 11 | GO:0051261 |
| GeneOntologyBiologicalProcess | actin filament capping | 3.92e-07 | 46 | 210 | 7 | GO:0051693 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 NCKAP1L | 4.81e-07 | 222 | 210 | 13 | GO:0008154 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | HSP90B1 ABI3 SPTB SPTBN1 SPTBN2 TAOK2 SPTBN5 PIK3CA TLN2 PLEC AMOTL2 MYO18B ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SMTN SPTBN4 TENM1 TNF ARHGEF2 NOS1AP NCKAP1L | 7.12e-07 | 803 | 210 | 25 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 SPTBN4 CCDC88C ARHGEF2 | 8.83e-07 | 197 | 210 | 12 | GO:1902904 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 9.50e-07 | 75 | 210 | 8 | GO:0030837 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SPTB SPTBN1 SPTBN2 TAOK2 SPTBN5 PHLDB1 PIK3CA PKD1 ESPN CAPZA1 CAPZA2 NUMA1 HIP1R SHROOM2 CIT SPTBN4 CCDC88C TENM1 ARHGEF2 NCKAP1L | 2.10e-06 | 579 | 210 | 20 | GO:0051493 |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 4.16e-06 | 91 | 210 | 8 | GO:0032272 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | SPTB SPTBN1 SPTBN2 SPTBN5 CAPZA1 CAPZA2 HIP1R SPTBN4 TENM1 NCKAP1L | 4.65e-06 | 156 | 210 | 10 | GO:0030833 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C IGF1R TNF ARHGEF2 | 9.58e-06 | 291 | 210 | 13 | GO:0032984 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 NUMA1 HIP1R SHROOM2 CIT SPTBN4 CCDC88C TENM1 ARHGEF2 NCKAP1L | 1.15e-05 | 438 | 210 | 16 | GO:1902903 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | SPTB SPTBN1 SPTBN2 SPTBN5 NLRC3 CAPZA1 CAPZA2 HIP1R SPTBN4 ARHGEF2 | 1.16e-05 | 173 | 210 | 10 | GO:0031333 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 NCKAP1L | 1.33e-05 | 300 | 210 | 13 | GO:0110053 |
| GeneOntologyBiologicalProcess | actin filament organization | HSP90B1 SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA PLEC ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 ARHGEF2 NCKAP1L | 1.94e-05 | 509 | 210 | 17 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin filament polymerization | SPTB SPTBN1 SPTBN2 SPTBN5 CAPZA1 CAPZA2 HIP1R SPTBN4 TENM1 NCKAP1L | 2.61e-05 | 190 | 210 | 10 | GO:0030041 |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | SPTB SPTBN1 SPTBN2 SPTBN5 CAPZA1 CAPZA2 NUMA1 HIP1R SPTBN4 TENM1 NCKAP1L | 2.62e-05 | 231 | 210 | 11 | GO:0032271 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA PML ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 SPTBN4 CCDC88C ARHGEF2 SLX4 | 2.90e-05 | 421 | 210 | 15 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | SPTB SPTBN1 SPTBN2 TAOK2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 NCKAP1L | 4.19e-05 | 384 | 210 | 14 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | SPTB SPTBN1 SPTBN2 SPTBN5 NLRC3 CAPZA1 CAPZA2 NUMA1 HIP1R SPTBN4 SKAP1 TENM1 TNF ARHGEF2 UNC13A NCKAP1L | 4.38e-05 | 489 | 210 | 16 | GO:0043254 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | HSP90B1 EPPK1 SPTB SPTBN1 SPTBN2 CCDC88B SPTBN5 PIK3CA PLEC ESPN CAPZA1 CAPZA2 NUMA1 HIP1R SHROOM2 CIT SPTBN4 CCDC88C INA ADAMTS7 TENM1 ARHGEF2 PCM1 NCKAP1L | 4.44e-05 | 957 | 210 | 24 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | SPTB SPTBN1 SPTBN2 TAOK2 SPTBN5 PIK3CA ANK2 CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 NCKAP1L | 4.56e-05 | 438 | 210 | 15 | GO:0032970 |
| GeneOntologyBiologicalProcess | cell junction organization | ABI3 SPTB SPTBN2 ITGAV TAOK2 TLN2 DLG4 PLEC ANK2 FKRP CAPZA1 HIP1R LAMB2 SPG11 PPFIA3 GRM6 SHROOM2 SPTBN4 IGF1R INA MACF1 TNF UNC13A NOS1AP | 5.86e-05 | 974 | 210 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 6.92e-05 | 99 | 210 | 7 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 7.37e-05 | 100 | 210 | 7 | GO:0045103 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | HSP90B1 JPH4 HK1 ITGAV PLCB3 PML ANK2 FKRP CHD7 GRIK5 VPS13D | 7.39e-05 | 259 | 210 | 11 | GO:0051651 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | ABI3 SPTB SPTBN1 SPTBN2 ITGAV SPTBN5 PIK3CA DLG4 NLRC3 NOTCH1 PML ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 CCDC88C TNF ARHGEF2 SLX4 | 7.54e-05 | 864 | 210 | 22 | GO:0051129 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TBC1D9B ABI3 SPTB SPTBN1 SPTBN2 SPTBN5 PHLDB1 PIK3CA DLG4 NLRC3 NOTCH1 ESPN CAPZA1 CAPZA2 NUMA1 HIP1R SPTBN4 SKAP1 HGS TENM1 MACF1 TNF ARHGEF2 CROCC UNC13A SLX4 NCKAP1L | 7.92e-05 | 1189 | 210 | 27 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SPTB SPTBN1 SPTBN2 SPTBN5 PIK3CA CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SPTBN4 TENM1 MACF1 NCKAP1L | 1.26e-04 | 426 | 210 | 14 | GO:0032535 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.62e-04 | 11 | 210 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | SPTB SPTBN1 SPTBN2 DELE1 SPTBN5 PIK3CA DEDD2 CAPZA1 CAPZA2 SHROOM2 SPTBN4 CCDC88C VPS13D IGF1R TNF ARHGEF2 PBXIP1 | 2.05e-04 | 617 | 210 | 17 | GO:0022411 |
| GeneOntologyBiologicalProcess | cellular response to hydrostatic pressure | 3.07e-04 | 3 | 210 | 2 | GO:0071464 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 3.07e-04 | 3 | 210 | 2 | GO:0071228 | |
| GeneOntologyCellularComponent | spectrin | 1.16e-08 | 9 | 209 | 5 | GO:0008091 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | SPTB SPTBN1 SPTBN2 SPTBN5 DLG4 CAPZA1 CAPZA2 NUMA1 HIP1R SHROOM2 SPTBN4 | 7.28e-08 | 129 | 209 | 11 | GO:0030863 |
| GeneOntologyCellularComponent | cell cortex | SPTB SPTBN1 SPTBN2 PARD6G SPTBN5 PHLDB1 DLG4 EXOC3L2 CAPZA1 CAPZA2 NUMA1 HIP1R PPFIA3 SHROOM2 SPTBN4 MACF1 UNC13A | 2.16e-07 | 371 | 209 | 17 | GO:0005938 |
| GeneOntologyCellularComponent | actin cytoskeleton | SPTB SPTBN1 SPTBN2 TAOK2 SPTBN5 TLN2 MYO18B FERMT3 ESPN CAPZA1 CAPZA2 HIP1R SHROOM2 CIT SMTN SPTBN4 MACF1 ARHGEF2 CROCC NOS1AP | 1.47e-06 | 576 | 209 | 20 | GO:0015629 |
| GeneOntologyCellularComponent | anchoring junction | HSP90B1 EPPK1 SPTBN2 PARD6G EVPL ITGAV UBA1 PIK3CA TLN2 DLG4 PLEC BCAR3 AMOTL2 NOTCH1 FERMT3 ESPN JCAD ANK2 KRT18 SYNM CAPZA1 SHROOM2 SPTBN4 CCDC88C SKAP1 ARHGEF2 NOS1AP | 1.69e-06 | 976 | 209 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | EPPK1 SPTBN2 PARD6G EVPL UBA1 PIK3CA TLN2 DLG4 AMOTL2 NOTCH1 JCAD ANK2 KRT18 SYNM CAPZA1 SHROOM2 SPTBN4 CCDC88C SKAP1 ARHGEF2 | 2.18e-06 | 591 | 209 | 20 | GO:0005911 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 4.13e-05 | 93 | 209 | 7 | GO:0030864 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 7.92e-05 | 9 | 209 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | cell cortex region | 8.40e-05 | 45 | 209 | 5 | GO:0099738 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EPPK1 EVPL JAKMIP1 PLEC MYO18B TBCC ESPN KRT18 SYNM NUMA1 LMNB2 SHROOM2 SMTN SPTBN4 KIFAP3 CCT6A INA MACF1 ARHGEF2 PBXIP1 PCNT | 2.79e-04 | 899 | 209 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | EPPK1 SPTBN1 EVPL JAKMIP1 PLEC MYO18B TBCC ESPN ANK2 KRT18 SYNM FKRP NUMA1 LMNB2 SHROOM2 SMTN SPTBN4 KIFAP3 CCT6A INA MACF1 ARHGEF2 PBXIP1 NOS1AP PCNT | 3.19e-04 | 1179 | 209 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EPPK1 SPTBN1 EVPL JAKMIP1 PLEC MYO18B TBCC ESPN ANK2 KRT18 SYNM FKRP NUMA1 LMNB2 SHROOM2 SMTN SPTBN4 KIFAP3 CCT6A INA MACF1 ARHGEF2 PBXIP1 NOS1AP PCNT | 3.52e-04 | 1187 | 209 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | alphav-beta3 integrin-IGF-1-IGF1R complex | 5.89e-04 | 4 | 209 | 2 | GO:0035867 | |
| GeneOntologyCellularComponent | sarcolemma | 6.71e-04 | 190 | 209 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | ruffle | 1.13e-03 | 206 | 209 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | costamere | 1.32e-03 | 22 | 209 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | postsynapse | ABI3 SPTB SPTBN1 SPTBN2 TAOK2 DLG4 PLCB3 NOTCH1 ANK2 HIP1R LAMA2 GRIK4 GRIK5 GRM6 KIFAP3 IGF1R INA ELAVL1 MACF1 ARHGEF2 NOS1AP | 1.37e-03 | 1018 | 209 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.45e-03 | 6 | 209 | 2 | GO:0032983 | |
| MousePheno | acanthocytosis | 6.22e-06 | 11 | 168 | 4 | MP:0010177 | |
| Domain | Spectrin_repeat | 5.76e-10 | 29 | 202 | 8 | IPR002017 | |
| Domain | SPEC | 1.37e-09 | 32 | 202 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.37e-09 | 32 | 202 | 8 | IPR018159 | |
| Domain | ACTININ_2 | 3.30e-09 | 23 | 202 | 7 | PS00020 | |
| Domain | ACTININ_1 | 3.30e-09 | 23 | 202 | 7 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.30e-09 | 23 | 202 | 7 | IPR001589 | |
| Domain | Spectrin_bsu | 1.33e-08 | 4 | 202 | 4 | IPR016343 | |
| Domain | CH | 3.21e-08 | 65 | 202 | 9 | SM00033 | |
| Domain | CH | 6.23e-08 | 70 | 202 | 9 | PF00307 | |
| Domain | - | 7.07e-08 | 71 | 202 | 9 | 1.10.418.10 | |
| Domain | CH | 9.05e-08 | 73 | 202 | 9 | PS50021 | |
| Domain | CH-domain | 1.15e-07 | 75 | 202 | 9 | IPR001715 | |
| Domain | Spectrin | 1.29e-07 | 23 | 202 | 6 | PF00435 | |
| Domain | - | 1.96e-07 | 6 | 202 | 4 | 3.90.1290.10 | |
| Domain | Plectin | 4.53e-07 | 7 | 202 | 4 | PF00681 | |
| Domain | Plectin_repeat | 4.53e-07 | 7 | 202 | 4 | IPR001101 | |
| Domain | PLEC | 4.53e-07 | 7 | 202 | 4 | SM00250 | |
| Domain | PH_dom-spectrin-type | 1.60e-06 | 9 | 202 | 4 | IPR001605 | |
| Domain | PH_dom-like | SPTBN1 SPTBN2 LYST SPTBN5 PHLDB1 TLN2 PLCB3 FERMT3 ARHGAP9 CIT SPTBN4 ARHGEF40 SKAP1 ARHGEF2 NOS1AP | 6.47e-05 | 426 | 202 | 15 | IPR011993 |
| Domain | - | SPTBN1 SPTBN2 SPTBN5 PHLDB1 TLN2 PLCB3 FERMT3 ARHGAP9 CIT SPTBN4 ARHGEF40 SKAP1 ARHGEF2 NOS1AP | 9.54e-05 | 391 | 202 | 14 | 2.30.29.30 |
| Domain | Ank_2 | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 1.21e-04 | 215 | 202 | 10 | PF12796 |
| Domain | PH | SPTBN1 SPTBN2 SPTBN5 PHLDB1 FERMT3 ARHGAP9 CIT SPTBN4 SKAP1 ARHGEF2 | 2.02e-04 | 229 | 202 | 10 | PF00169 |
| Domain | PH | SPTBN1 SPTBN2 SPTBN5 PHLDB1 FERMT3 ARHGAP9 CIT SPTBN4 ARHGEF40 SKAP1 ARHGEF2 | 2.31e-04 | 278 | 202 | 11 | SM00233 |
| Domain | PH_DOMAIN | SPTBN1 SPTBN2 SPTBN5 PHLDB1 FERMT3 ARHGAP9 CIT SPTBN4 ARHGEF40 SKAP1 ARHGEF2 | 2.38e-04 | 279 | 202 | 11 | PS50003 |
| Domain | PH_domain | SPTBN1 SPTBN2 SPTBN5 PHLDB1 FERMT3 ARHGAP9 CIT SPTBN4 ARHGEF40 SKAP1 ARHGEF2 | 2.45e-04 | 280 | 202 | 11 | IPR001849 |
| Domain | DUF3454 | 3.47e-04 | 3 | 202 | 2 | PF11936 | |
| Domain | F_ACTIN_CAPPING_A_1 | 3.47e-04 | 3 | 202 | 2 | PS00748 | |
| Domain | F_ACTIN_CAPPING_A_2 | 3.47e-04 | 3 | 202 | 2 | PS00749 | |
| Domain | F-actin_cap_A | 3.47e-04 | 3 | 202 | 2 | PF01267 | |
| Domain | CapZ_alpha | 3.47e-04 | 3 | 202 | 2 | IPR002189 | |
| Domain | F-actin_cap_asu_CS | 3.47e-04 | 3 | 202 | 2 | IPR017865 | |
| Domain | DUF3454_notch | 3.47e-04 | 3 | 202 | 2 | IPR024600 | |
| Domain | DUF3454 | 3.47e-04 | 3 | 202 | 2 | SM01334 | |
| Domain | - | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 3.82e-04 | 248 | 202 | 10 | 1.25.40.20 |
| Domain | ANK | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 4.20e-04 | 251 | 202 | 10 | SM00248 |
| Domain | ANK_REPEAT | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 4.47e-04 | 253 | 202 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 4.61e-04 | 254 | 202 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 4.61e-04 | 254 | 202 | 10 | PS50297 |
| Domain | Ankyrin_rpt | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 5.86e-04 | 262 | 202 | 10 | IPR002110 |
| Domain | ILWEQ_dom | 6.88e-04 | 4 | 202 | 2 | IPR002558 | |
| Domain | Notch | 6.88e-04 | 4 | 202 | 2 | IPR008297 | |
| Domain | ILWEQ | 6.88e-04 | 4 | 202 | 2 | SM00307 | |
| Domain | NODP | 6.88e-04 | 4 | 202 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 6.88e-04 | 4 | 202 | 2 | IPR011656 | |
| Domain | ILWEQ | 6.88e-04 | 4 | 202 | 2 | PD011820 | |
| Domain | - | 6.88e-04 | 4 | 202 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 6.88e-04 | 4 | 202 | 2 | PF01608 | |
| Domain | I_LWEQ | 6.88e-04 | 4 | 202 | 2 | PS50945 | |
| Domain | N-RASSF | 6.88e-04 | 4 | 202 | 2 | IPR033593 | |
| Domain | Notch_NOD_dom | 6.88e-04 | 4 | 202 | 2 | IPR010660 | |
| Domain | NOD | 6.88e-04 | 4 | 202 | 2 | PF06816 | |
| Domain | NOD | 6.88e-04 | 4 | 202 | 2 | SM01338 | |
| Domain | NODP | 6.88e-04 | 4 | 202 | 2 | SM01339 | |
| Domain | Ank | 8.66e-04 | 228 | 202 | 9 | PF00023 | |
| Domain | Laminin_domII | 1.14e-03 | 5 | 202 | 2 | IPR010307 | |
| Domain | Laminin_aI | 1.14e-03 | 5 | 202 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.14e-03 | 5 | 202 | 2 | PF06008 | |
| Domain | Laminin_II | 1.14e-03 | 5 | 202 | 2 | PF06009 | |
| Domain | LNR | 1.14e-03 | 5 | 202 | 2 | PS50258 | |
| Domain | BRK | 1.70e-03 | 6 | 202 | 2 | SM00592 | |
| Domain | HOOK | 1.70e-03 | 6 | 202 | 2 | PF05622 | |
| Domain | BRK_domain | 1.70e-03 | 6 | 202 | 2 | IPR006576 | |
| Domain | Hook-related_fam | 1.70e-03 | 6 | 202 | 2 | IPR008636 | |
| Domain | BRK | 1.70e-03 | 6 | 202 | 2 | PF07533 | |
| Domain | Notch_dom | 2.36e-03 | 7 | 202 | 2 | IPR000800 | |
| Domain | Notch | 2.36e-03 | 7 | 202 | 2 | PF00066 | |
| Domain | NL | 2.36e-03 | 7 | 202 | 2 | SM00004 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.51e-08 | 10 | 144 | 5 | MM15112 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.11e-07 | 31 | 144 | 6 | M877 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 9.52e-06 | 102 | 144 | 8 | M27648 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.32e-05 | 121 | 144 | 8 | M872 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.97e-05 | 38 | 144 | 5 | MM14969 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.65e-05 | 68 | 144 | 6 | MM14968 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.19e-04 | 10 | 144 | 3 | M10272 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.98e-04 | 156 | 144 | 8 | M27097 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.15e-04 | 12 | 144 | 3 | MM15142 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.33e-04 | 30 | 144 | 4 | M18193 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.33e-04 | 30 | 144 | 4 | M27216 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.01e-04 | 32 | 144 | 4 | MM15143 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 TBC1D9B EPPK1 RNF40 LYST TAOK2 ZGPAT PHLDB1 KCNH2 PKD1 NCAPD2 TLN2 PLEC DOCK6 NOTCH1 NOTCH2 SZT2 HIP1R LAMB2 CHD8 MIB2 LMNB2 FAAP100 CIT RASSF7 TRIM7 CCDC142 KANSL3 LPIN3 CCDC88C ARHGEF40 TKFC IGF1R SUGP2 ADAMTS7 PLA2G4B ARHGEF2 ZNF839 CD276 PCNT | 8.82e-20 | 1105 | 212 | 40 | 35748872 |
| Pubmed | SPTBN1 SPTBN2 ZNF318 TAOK2 UBA1 MIOS TLN2 DLG4 JAKMIP1 NOP2 GOLGA3 FERMT3 MAGED1 ANK2 CAPZA2 NUMA1 CHD8 CHD7 GRIK5 LMNB2 PPFIA3 IPO4 CIT SPTBN4 CCDC88C INA ELAVL1 MACF1 ARHGEF2 UNC13A PCM1 PCNT | 6.73e-15 | 963 | 212 | 32 | 28671696 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSP90B1 EPPK1 IRF2BP1 SPTBN2 ZNF318 PFKL PHLDB1 UBA1 DDX54 ABCD3 MACROH2A2 PLEC NOP2 KRT18 CAPZA1 CAPZA2 NUMA1 LAMB2 LMNB2 CIT GADD45GIP1 CCT6A INA NUP155 SUGP2 ELAVL1 MACF1 ARHGEF2 PCM1 PCNT | 1.26e-12 | 1024 | 212 | 30 | 24711643 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TBC1D9B PFKL RAD54L2 CCDC88B PHLDB1 DLG4 JAKMIP1 GOLGA3 NOTCH1 NOTCH2 PML ERVFRD-1 ANKRD35 MAGED1 KRT18 TNIP2 LAMB2 SPTBN4 INA HGS ELAVL1 ANKS3 | 6.03e-12 | 560 | 212 | 22 | 21653829 |
| Pubmed | HSP90B1 SPTB SPTBN1 EVPL UBA1 PLEC GOLGA3 PML KRT18 SYNM NUMA1 LMNB2 NPEPL1 CCT6A ELAVL1 MACF1 PBXIP1 PCNT | 1.10e-11 | 360 | 212 | 18 | 33111431 | |
| Pubmed | HSP90B1 HK1 SPTB SPTBN1 SPTBN2 PFKL PHLDB1 UBA1 ABCD3 MIOS TLN2 DLG4 PLEC TSC22D4 GOLGA3 ANK2 CAPZA1 CAPZA2 PPFIA3 SHROOM2 CIT LRCH3 SPTBN4 CCT6A INA SUGP2 ELAVL1 MACF1 ARHGEF2 CROCC PBXIP1 UNC13A PCM1 | 5.17e-11 | 1431 | 212 | 33 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 DIS3L2 HK1 SPTBN1 PFKL ZGPAT PHLDB1 UBA1 DDX54 NCAPD2 ABCD3 MACROH2A2 PLEC NOP2 KRT18 POLR1C CAPZA1 CAPZA2 NUMA1 HIP1R CHD8 CHD7 LMNB2 IPO4 SMTN CCT6A ARHGEF40 NUP155 SUGP2 ELAVL1 MACF1 ARHGEF2 | 5.55e-11 | 1353 | 212 | 32 | 29467282 |
| Pubmed | EPPK1 HK1 SPTBN1 SPTBN2 ZNF318 DDX54 NCAPD2 PLEC NOP2 NUMA1 CHD8 CHD7 LMNB2 IPO4 INA NUP155 SUGP2 ELAVL1 MACF1 PCM1 PCNT | 7.18e-10 | 653 | 212 | 21 | 22586326 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 8.35e-10 | 18 | 212 | 6 | 12119179 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | EPPK1 FANCG ABCD3 GNAI3 MAGED1 KRT18 CAPZA1 CAPZA2 IPO4 CCT6A TKFC AP5B1 PCM1 TEDC1 | 1.08e-09 | 264 | 212 | 14 | 32814769 |
| Pubmed | PRPSAP2 HSP90B1 SPTBN1 PFKL TAOK2 UBA1 ABCD3 TLN2 DLG4 PLEC JCAD MAGED1 ANK2 HIP1R MIB2 PPFIA3 SHROOM2 CIT CCT6A INA SUGP2 TENM1 UBR3 MACF1 UNC13A PCM1 NOS1AP | 1.95e-09 | 1139 | 212 | 27 | 36417873 | |
| Pubmed | FAM184B HSP90B1 HK1 SPTBN1 SPTBN2 HSPBP1 LCMT2 DDX54 ABCD3 TSC22D4 SLC30A9 NOP2 GOLGA3 NOTCH2 PML MAGED1 ERO1B ANK2 SYNM POLR1C SPG11 LMNB2 IPO4 NUP155 HGS MACF1 PBXIP1 HSPA14 PCM1 NOS1AP PCNT | 2.39e-09 | 1487 | 212 | 31 | 33957083 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSP90B1 EPPK1 SPTBN1 SPTBN2 EVPL PFKL UBA1 DDX54 ABCD3 GNAI3 PLEC NOP2 PML KRT18 SYNM POLR1C CAPZA1 CAPZA2 NUMA1 LMNB2 IPO4 CIT LRCH3 CCT6A NUP155 ELAVL1 ARHGEF2 HSPA14 | 3.71e-09 | 1257 | 212 | 28 | 36526897 |
| Pubmed | SPTBN1 PFKL RPRD1B MACROH2A2 GNAI3 PLEC NOP2 PML KRT18 POLR1C CAPZA1 CAPZA2 NUMA1 LMNB2 CIT NUP155 ELAVL1 MACF1 PCM1 NOS1AP | 5.09e-09 | 660 | 212 | 20 | 32780723 | |
| Pubmed | SPTBN1 SPTBN2 TAOK2 UBA1 TLN2 DLG4 ANK2 CAPZA2 GRIK5 CIT SPTBN4 INA MACF1 | 5.71e-09 | 251 | 212 | 13 | 27507650 | |
| Pubmed | HSP90B1 SPTB SPTBN1 SPTBN2 RNF40 RAD54L2 PKD1 TLN2 DLG4 JAKMIP1 PLEC AMOTL2 GOLGA3 JCAD MAGED1 ANK2 SYNM POLR1C CAPZA2 PDCD7 SHROOM2 CIT SPTBN4 MACF1 PBXIP1 SLX4 PCM1 PCNT | 5.98e-09 | 1285 | 212 | 28 | 35914814 | |
| Pubmed | 9.93e-09 | 13 | 212 | 5 | 18796539 | ||
| Pubmed | JPH4 SPTBN2 ITGAV SPTBN5 CROCC2 DDX54 PLCB3 PLEC MYO18B DOCK6 GOLGA3 KRT18 CAPZA2 LAMB2 LRCH3 MACF1 ZNF839 | 1.27e-08 | 496 | 212 | 17 | 31343991 | |
| Pubmed | HSP90B1 TBC1D9B HK1 IRF2BP1 SPTBN1 SPTBN2 PFKL DDX54 NCAPD2 ABCD3 SLC30A9 NOP2 PML MAGED1 KRT18 POLR1C CAPZA1 CAPZA2 NUMA1 IPO4 LRCH3 SMTN CCT6A NUP155 ELAVL1 ARHGEF2 STX10 PBXIP1 PCM1 | 1.77e-08 | 1440 | 212 | 29 | 30833792 | |
| Pubmed | FAM184B HSP90B1 HK1 SPTBN1 SPTBN2 ZNF318 RAD54L2 LYST NCAPD2 GNAI3 JAKMIP1 PLEC ESPN TTC24 ANK2 KRT18 PCDHGB5 CAPZA1 CAPZA2 NUMA1 SPG11 LMNB2 SPTBN4 CCT6A INA TENM1 MACF1 ARHGEF2 PCNT | 1.82e-08 | 1442 | 212 | 29 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 SPTBN1 LYST PHLDB1 PLEC TSC22D4 DOCK6 NOTCH2 PML JCAD KRT18 RASSF7 LPIN3 CCDC88C VPS13D IGF1R INA MACF1 NUB1 ARHGEF2 PCM1 NOS1AP | 1.83e-08 | 861 | 212 | 22 | 36931259 |
| Pubmed | SPTB SPTBN5 PHLDB1 PKD1 PLEC DNHD1 LMNB2 CCT6A INA CROCC PCNT | 2.37e-08 | 187 | 212 | 11 | 26460568 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | HSP90B1 EPPK1 SPTBN1 SPTBN2 FANCG UBA1 PLEC NOP2 MAGED1 NUMA1 LMNB2 PPFIA3 CCT6A NUP155 SUGP2 PCM1 | 4.66e-08 | 477 | 212 | 16 | 31300519 |
| Pubmed | CDK16 PARD6G ITGAV PHLDB1 PIK3CA GORAB GOLGA3 NOTCH2 LRCH3 IGF1R NUP155 HGS MACF1 STX10 NOS1AP | 5.68e-08 | 421 | 212 | 15 | 36976175 | |
| Pubmed | PRPSAP2 HSP90B1 SPTBN1 SPTBN2 TUSC1 UBA1 JAKMIP1 PLEC NOP2 GOLGA3 PML CAPZA1 CCDC88C CCT6A INA ELAVL1 ARHGEF2 | 5.84e-08 | 551 | 212 | 17 | 34728620 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | SPTBN1 ZNF318 ZGPAT FANCG DEDD2 DDX54 ABCD3 GNAI3 NOP2 NOTCH2 MAGED1 CAPZA1 NUMA1 CHD8 LMNB2 IPO4 LRCH3 ARHGEF2 | 6.45e-08 | 624 | 212 | 18 | 33729478 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPSAP2 HSP90B1 HK1 SPTBN1 MC1R HSPBP1 PFKL RPRD1B UBA1 NCAPD2 PLCB3 GNAI3 PLEC KRT18 POLR1C CAPZA1 CAPZA2 LAMB2 IPO4 GSS PRMT6 CCT6A TKFC NUP155 ASL HGS MACF1 CROCC | 8.21e-08 | 1455 | 212 | 28 | 22863883 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RNF40 ZNF318 MAP3K4 RPRD1B DDX54 ABCD3 MIOS NOP2 PML NUMA1 CHD8 LRCH3 NUP155 ARHGEF2 SLX4 | 1.01e-07 | 440 | 212 | 15 | 34244565 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP2 HSP90B1 EPPK1 SPTBN1 RNF40 HSPBP1 PFKL ZGPAT UBA1 DDX54 NCAPD2 ABCD3 PLCB3 PLEC NOP2 KRT18 POLR1C CAPZA1 CAPZA2 NUMA1 PDCD2L CCT6A NUP155 ELAVL1 MACF1 ARHGEF2 HSPA14 | 1.69e-07 | 1415 | 212 | 27 | 28515276 |
| Pubmed | PFKL RPRD1B DDX54 GNAI3 PLEC NOP2 GOLGA3 FERMT3 PML LMNB2 LRCH3 ELAVL1 PCNT | 2.00e-07 | 340 | 212 | 13 | 29478914 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 11294830 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 2.23e-07 | 3 | 212 | 3 | 32425157 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.74e-07 | 10 | 212 | 4 | 22159418 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | PFKL PLEC SLC30A9 GOLGA3 KRT18 TNIP2 CAPZA1 MIB2 CCT6A ELAVL1 TNF ARHGEF2 PCM1 | 3.06e-07 | 353 | 212 | 13 | 27545878 |
| Pubmed | 3.26e-07 | 147 | 212 | 9 | 16959763 | ||
| Pubmed | HSP90B1 SPTBN1 SPTBN2 EVPL CCDC88B MAP3K4 ZGPAT PLEC KRT18 LAMA4 LAMB2 CHD8 HGS MACF1 ZNF839 | 3.58e-07 | 486 | 212 | 15 | 20936779 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HSP90B1 GHDC SPTBN1 ITGAV REEP6 NCAPD2 ABCD3 GNAI3 PLEC SLC30A9 NOP2 NOTCH2 PML MAGED1 KRT18 LAMB2 CHD8 LMNB2 KIFAP3 IGF1R NUP155 PBXIP1 SLX4 CD276 | 3.94e-07 | 1203 | 212 | 24 | 29180619 |
| Pubmed | CDK16 EPPK1 HK1 SPTBN2 HSPBP1 UBA1 PIK3CA DDX54 AMOTL2 NOP2 LENG1 HIP1R HGS ELAVL1 MACF1 PBXIP1 PCM1 | 4.21e-07 | 634 | 212 | 17 | 34591612 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSP90B1 EPPK1 SPTBN1 SPTBN2 PFKL DDX54 GNAI3 PLEC BCAR3 NOP2 KRT18 CAPZA1 CAPZA2 NUMA1 LAMB2 LRCH3 SMTN CCT6A NUP155 ELAVL1 ARHGEF2 | 4.23e-07 | 949 | 212 | 21 | 36574265 |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 4.28e-07 | 11 | 212 | 4 | 17607528 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | HK1 SPTB SPTBN2 EVPL PFKL UBA1 CROCC2 ABCD3 GNAI3 NOP2 MAGED1 HIP1R LMNB2 CIT CCT6A ARHGEF40 NUB1 PCNT | 6.66e-07 | 732 | 212 | 18 | 34732716 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HSP90B1 EPPK1 SPTBN1 NCAPD2 TLN2 PLEC CAPZA1 HIP1R CHD8 CHD7 CCT6A NUP155 ELAVL1 MACF1 ARHGEF2 PCNT | 6.72e-07 | 582 | 212 | 16 | 20467437 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | HSP90B1 IRF2BP1 PFKL RAD54L2 MACROH2A2 NOP2 PML KRT18 NUMA1 CCT6A SLX4 | 7.09e-07 | 262 | 212 | 11 | 36880596 |
| Pubmed | 7.35e-07 | 210 | 212 | 10 | 16565220 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RNF40 ZNF318 RAD54L2 PTK6 PML MAGED1 CAPZA1 CAPZA2 CHD7 IPO4 KANSL3 MACF1 SLX4 PCM1 PCNT TEDC1 | 7.69e-07 | 588 | 212 | 16 | 38580884 |
| Pubmed | HSP90B1 ABI3 GHDC DPM3 RNF40 PFKL CCDC88B DDX54 NCAPD2 ABCD3 GNAI3 GOLGA3 NOTCH2 FERMT3 PDCD2L IPO4 CIT NUP155 ELAVL1 HSPA14 PCM1 PCNT NCKAP1L | 8.74e-07 | 1168 | 212 | 23 | 19946888 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 21412925 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | SPTBN1 GNAI3 PLEC KRT18 CAPZA1 CAPZA2 LMNB2 LRCH3 CCT6A INA ELAVL1 PCM1 | 9.45e-07 | 328 | 212 | 12 | 23398456 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | EPPK1 SPTBN1 MACROH2A2 PLEC KRT18 POLR1C NUMA1 LAMB2 CHD8 CCT6A | 1.08e-06 | 219 | 212 | 10 | 31353912 |
| Pubmed | HSP90B1 HSPBP1 UBA1 TLN2 DLG4 ANK2 CAPZA1 LAMB2 LMNB2 CIT HGS MACF1 | 1.42e-06 | 341 | 212 | 12 | 29791485 | |
| Pubmed | 1.52e-06 | 131 | 212 | 8 | 28031328 | ||
| Pubmed | 1.52e-06 | 131 | 212 | 8 | 28634551 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D9B GHDC HSPBP1 TAOK2 NCAPD2 ABCD3 SLC30A9 MAGED1 KRT18 FKRP POLR1C RDH14 PDCD2L LMNB2 IPO4 ARHGEF40 NUP155 TNF ARHGEF2 HSPA14 | 1.52e-06 | 942 | 212 | 20 | 31073040 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HSP90B1 ABI3 SPTBN1 RNF40 MIOS TLN2 MACROH2A2 PLCB3 NOP2 MAGED1 CHD8 NUP155 ELAVL1 PCM1 | 1.52e-06 | 475 | 212 | 14 | 31040226 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | HSP90B1 HK1 SPTB SPTBN1 PFKL DLG4 GNAI3 CAPZA1 CAPZA2 GRIK5 LMNB2 PPFIA3 CCT6A IGF1R INA ARHGEF2 | 1.56e-06 | 621 | 212 | 16 | 22794259 |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 22632975 | ||
| Pubmed | Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. | 2.21e-06 | 5 | 212 | 3 | 11369940 | |
| Pubmed | IRF2BP1 SPTBN1 MC1R ZNF318 RAD54L2 NFKBIB DDX54 ABCD3 NOP2 PML MAGED1 TNIP2 NUMA1 CHD8 CHD7 CIT GADD45GIP1 KANSL3 CCT6A ANGPTL6 SUGP2 HGS ELAVL1 SLX4 PCM1 | 2.39e-06 | 1429 | 212 | 25 | 35140242 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | HSPBP1 CCDC88B PHLDB1 TLN2 MYO18B ANKRD35 TNIP2 MIB2 GRM6 SPTBN4 ASL MACF1 | 2.55e-06 | 361 | 212 | 12 | 26167880 |
| Pubmed | PRPSAP2 BICDL2 HSP90B1 EPPK1 SPTBN1 RNF40 REEP6 JAKMIP1 PLEC FERMT3 LNX2 RASSF7 TRIM7 SMTN | 2.96e-06 | 503 | 212 | 14 | 36217030 | |
| Pubmed | ITGAV LYST DDX54 ABCD3 MIOS DOCK6 GOLGA3 NOTCH2 SPG11 LRCH3 VPS13D NUP155 TENM1 STX10 | 3.03e-06 | 504 | 212 | 14 | 34432599 | |
| Pubmed | CDK16 AMOTL2 DOCK6 NOTCH1 NOTCH2 JCAD LNX2 MAGED1 LRCH3 CCDC88C HGS ARHGEF2 PCM1 | 4.09e-06 | 446 | 212 | 13 | 24255178 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CDK16 HK1 RPRD1B NCAPD2 ABCD3 NOP2 PML DNHD1 ERO1B CAPZA1 NUMA1 TSEN54 ITIH5 NUB1 HSPA14 PCNT | 4.11e-06 | 670 | 212 | 16 | 22990118 |
| Pubmed | HSP90B1 EPPK1 IRF2BP1 SPTBN1 RNF40 PHLDB1 ABCD3 NOP2 GOLGA3 JCAD LENG1 CAPZA1 LMNB2 PPFIA3 CCT6A INA ELAVL1 | 4.37e-06 | 754 | 212 | 17 | 35906200 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 20060382 | ||
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 4.41e-06 | 6 | 212 | 3 | 18817539 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 4.41e-06 | 6 | 212 | 3 | 23728480 | |
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 4.41e-06 | 6 | 212 | 3 | 16687515 | |
| Pubmed | 5.59e-06 | 156 | 212 | 8 | 37108203 | ||
| Pubmed | SPTB DELE1 ITGAV TAOK2 DEDD2 PKD1 NCAPD2 PLCB3 BCAR3 NOTCH1 C14orf93 ANK2 LAMA2 LAMB2 CHD8 FAAP100 IGF1R AP5B1 TENM1 NUB1 ARHGEF2 HSPA14 | 5.87e-06 | 1215 | 212 | 22 | 15146197 | |
| Pubmed | HSP90B1 HK1 SPTBN1 EVPL PFKL UBA1 NOP2 NUMA1 LMNB2 CCT6A MACF1 | 6.01e-06 | 327 | 212 | 11 | 31409639 | |
| Pubmed | 6.02e-06 | 20 | 212 | 4 | 18723693 | ||
| Pubmed | EPPK1 SPTBN1 PLEC AMOTL2 NOP2 GOLGA3 NUMA1 CHD8 MACF1 ARHGEF2 PCM1 | 6.93e-06 | 332 | 212 | 11 | 37433992 | |
| Pubmed | 7.40e-06 | 21 | 212 | 4 | 24923560 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 14557481 | ||
| Pubmed | EMX2-GPR156-Gαi reverses hair cell orientation in mechanosensory epithelia. | 9.01e-06 | 22 | 212 | 4 | 34001891 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | HSP90B1 EPPK1 HK1 SPTBN1 PARD6G HSPBP1 PKD1 PLEC KRT18 SMTN CCT6A ANGPTL6 VPS13D PCM1 | 1.08e-05 | 564 | 212 | 14 | 21565611 |
| Pubmed | 1.09e-05 | 23 | 212 | 4 | 16998848 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTBN1 SPTBN2 EVPL VSIG10L PLCB3 PLEC GOLGA3 NOTCH1 NOTCH2 JCAD KRT18 CAPZA1 LRATD2 MACF1 | 1.10e-05 | 565 | 212 | 14 | 25468996 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | HSP90B1 TBC1D9B EPPK1 SPTBN1 MC1R PFKL UBA1 NCAPD2 PLEC KRT18 CAPZA1 CAPZA2 LMNB2 IPO4 UBR3 | 1.17e-05 | 647 | 212 | 15 | 26618866 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSP90B1 HK1 SPTBN1 SPTBN2 ABCD3 MIOS MACROH2A2 PLEC DOCK6 CHD7 LMNB2 PDCD7 CCT6A INA SUGP2 ELAVL1 MACF1 ARHGEF2 PBXIP1 UNC13A | 1.18e-05 | 1082 | 212 | 20 | 38697112 |
| Pubmed | HSP90B1 EPPK1 SPTBN1 EVPL FANCG PLEC NOP2 PML KRT18 POLR1C CAPZA2 NUMA1 LMNB2 FAAP100 ELAVL1 | 1.28e-05 | 652 | 212 | 15 | 31180492 | |
| Pubmed | BICDL2 MXD3 LRRC45 HSPBP1 PTK6 ZGPAT REEP6 TSC22D4 AMOTL2 LNX2 MAGED1 KRT18 LENG1 POLR1C RASSF7 KIFAP3 ASL SKAP1 HGS CCDC68 LRATD2 ARHGEF2 PBXIP1 PCM1 | 1.32e-05 | 1477 | 212 | 24 | 31515488 | |
| Pubmed | 1.44e-05 | 233 | 212 | 9 | 29518331 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | HSP90B1 EPPK1 SPTBN1 SPTBN2 UBA1 ABCD3 GNAI3 PLEC NOP2 KRT18 CAPZA1 CAPZA2 LRCH3 ARHGEF2 | 1.48e-05 | 580 | 212 | 14 | 35676659 |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.54e-05 | 25 | 212 | 4 | 8493579 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SPTBN1 EVPL PFKL ITGAV UBA1 PKD1 GNAI3 DNHD1 AMN CAPZA1 CAPZA2 SHROOM2 GSS CCT6A VPS13D TKFC ASL HGS CROCC | 1.68e-05 | 1016 | 212 | 19 | 19056867 |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.94e-05 | 90 | 212 | 6 | 35654790 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RNF40 ZNF318 RAD54L2 UBA1 PML MAGED1 KRT18 CHD8 SMTN KANSL3 CCT6A SLX4 | 2.04e-05 | 444 | 212 | 12 | 34795231 |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 2.38e-05 | 56 | 212 | 5 | 9455484 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SPTBN1 ZNF318 RPRD1B UBA1 TLN2 PLCB3 PLEC NOP2 NOTCH2 NUMA1 CHD7 SMTN KANSL3 SUGP2 ARHGEF2 PCM1 | 2.43e-05 | 774 | 212 | 16 | 15302935 |
| Pubmed | RNF40 TAOK2 NCAPD2 AMOTL2 DOCK6 SZT2 HIP1R CHD8 SPG11 NPEPL1 KANSL3 NUP155 ANKS3 | 2.49e-05 | 529 | 212 | 13 | 14621295 | |
| Pubmed | 2.60e-05 | 10 | 212 | 3 | 9034910 | ||
| Pubmed | HSP90B1 SPTBN1 SPTBN2 UBA1 DDX54 ABCD3 MIOS MACROH2A2 NOTCH1 JCAD KRT18 PPFIA3 PPP1R3D NUP155 HGS UBR3 ARHGEF2 NOS1AP PCNT | 2.60e-05 | 1049 | 212 | 19 | 27880917 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPSAP2 HSP90B1 EPPK1 HK1 SPTBN1 SPTBN2 PFKL UBA1 NCAPD2 PLEC MAGED1 KRT18 CAPZA1 CAPZA2 IPO4 GSS CCT6A INA ELAVL1 MACF1 | 2.78e-05 | 1149 | 212 | 20 | 35446349 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.04e-05 | 197 | 212 | 8 | 20811636 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP2 EPPK1 HK1 MAP3K4 ABCD3 GNAI3 POLR1C CAPZA2 NUMA1 GRIK5 IPO4 CCT6A SUGP2 ELAVL1 HSPA14 | 3.11e-05 | 704 | 212 | 15 | 29955894 |
| Pubmed | SPTBN1 PFKL ITGAV GNAI3 PLEC FERMT3 KRT18 POLR1C CAPZA1 HIP1R IPO4 CCT6A NUP155 ELAVL1 MACF1 | 3.27e-05 | 707 | 212 | 15 | 19738201 | |
| Pubmed | HSP90B1 EPPK1 SPTBN1 PFKL ZGPAT DDX54 GNAI3 PLEC NOP2 HIP1R LMNB2 IPO4 TKFC NUP155 MACF1 | 3.48e-05 | 711 | 212 | 15 | 33022573 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 3.55e-05 | 11 | 212 | 3 | 23472759 | |
| Interaction | TOP3B interactions | VWA5B2 HSP90B1 TBC1D9B EPPK1 SPTB SPTBN2 RNF40 PFKL LYST TAOK2 ZGPAT PHLDB1 KCNH2 PKD1 NCAPD2 TLN2 GNAI3 PLEC DOCK6 NOP2 NOTCH1 NOTCH2 SZT2 HIP1R LAMB2 CHD8 MIB2 LMNB2 IPO4 FAAP100 CIT RASSF7 TRIM7 CCDC142 KANSL3 LPIN3 CCDC88C ARHGEF40 TKFC IGF1R SUGP2 ADAMTS7 PLA2G4B ELAVL1 ARHGEF2 ZNF839 CD276 PCNT | 5.38e-13 | 1470 | 208 | 48 | int:TOP3B |
| Interaction | SHANK3 interactions | SPTBN1 SPTBN2 ZNF318 PFKL TAOK2 PHLDB1 UBA1 TLN2 DLG4 NOTCH1 NOTCH2 ANKRD35 ANK2 TNIP2 CAPZA2 NUMA1 CIT SPTBN4 INA HGS ELAVL1 MACF1 | 1.03e-08 | 496 | 208 | 22 | int:SHANK3 |
| Interaction | KIF20A interactions | EPPK1 SPTB SPTBN1 SPTBN2 ZNF318 ABCD3 MACROH2A2 GNAI3 PLEC NOP2 PML ANKRD35 ANK2 TNIP2 POLR1C CAPZA1 CAPZA2 NUMA1 CHD8 LMNB2 CIT GADD45GIP1 LRCH3 TRIM7 SMTN SPTBN4 INA NUP155 SUGP2 ELAVL1 MACF1 PCM1 | 3.85e-08 | 1052 | 208 | 32 | int:KIF20A |
| Interaction | YWHAH interactions | CDK16 EPPK1 SPTBN1 PARD6G LYST PHLDB1 UBA1 PIK3CA KCNH2 GNAI3 JAKMIP1 PLEC TSC22D4 AMOTL2 DOCK6 NOTCH2 JCAD KRT18 RASSF7 GSS LPIN3 PPP1R3D CCDC88C VPS13D INA ELAVL1 MACF1 NUB1 ARHGEF2 PCM1 NOS1AP PCNT | 1.12e-07 | 1102 | 208 | 32 | int:YWHAH |
| Interaction | OBSL1 interactions | HSP90B1 JPH4 EPPK1 IRF2BP1 SPTBN2 UBA1 CROCC2 DDX54 ABCD3 MACROH2A2 PLEC NOP2 GOLGA3 NOTCH2 KRT18 CAPZA1 CAPZA2 NUMA1 LMNB2 CIT CCT6A INA NUP155 SUGP2 ELAVL1 MACF1 PCM1 PCNT | 1.99e-07 | 902 | 208 | 28 | int:OBSL1 |
| Interaction | CCDC8 interactions | HSP90B1 EPPK1 SPTBN2 ZNF318 PFKL PHLDB1 UBA1 PLEC NOP2 KRT18 CAPZA2 NUMA1 LAMB2 LMNB2 GADD45GIP1 CCT6A NUP155 SUGP2 ELAVL1 MACF1 ARHGEF2 PCM1 PCNT | 3.35e-07 | 656 | 208 | 23 | int:CCDC8 |
| Interaction | YWHAZ interactions | CDK16 SPTBN1 SPTBN2 PARD6G PFKL LYST MAP3K4 PHLDB1 UBA1 DLG4 JAKMIP1 PLEC TSC22D4 GOLGA3 PML JCAD LNX2 KRT18 CAPZA2 HIP1R PPFIA3 TRIM7 LPIN3 PPP1R3D CCDC88C VPS13D IGF1R INA MACF1 NUB1 ARHGEF2 ZNF839 PCM1 PCNT | 6.91e-07 | 1319 | 208 | 34 | int:YWHAZ |
| Interaction | KCTD13 interactions | HSP90B1 HK1 SPTB SPTBN1 SPTBN2 PFKL PHLDB1 UBA1 ABCD3 MIOS TLN2 DLG4 PLEC TSC22D4 GOLGA3 MAGED1 ANK2 POLR1C CAPZA1 CAPZA2 PPFIA3 SHROOM2 CIT LRCH3 SPTBN4 CCT6A INA SUGP2 ELAVL1 MACF1 ARHGEF2 CROCC PBXIP1 UNC13A PCM1 | 8.50e-07 | 1394 | 208 | 35 | int:KCTD13 |
| Interaction | PRC1 interactions | HSP90B1 EPPK1 SPTB SPTBN1 SPTBN2 PFKL MAP3K4 CCDC154 DDX54 ABCD3 MACROH2A2 PLEC NOP2 NOTCH2 FERMT3 ANKRD35 POLR1C CAPZA2 NUMA1 SPG11 LMNB2 CIT SPTBN4 CCT6A CCDC68 ELAVL1 UNC13A PCM1 | 9.09e-07 | 973 | 208 | 28 | int:PRC1 |
| Interaction | CIT interactions | HSP90B1 EPPK1 GHDC SPTB SPTBN1 SPTBN2 RNF40 DELE1 PFKL MAP3K4 RPRD1B UBA1 ABCD3 DLG4 MACROH2A2 PLEC NOP2 ANKRD35 POLR1C CAPZA1 CAPZA2 NUMA1 CHD8 LMNB2 PDCD7 CIT SPTBN4 CCT6A INA NUP155 SUGP2 HGS ELAVL1 MACF1 ARHGEF2 | 2.09e-06 | 1450 | 208 | 35 | int:CIT |
| Interaction | GAN interactions | SPTB SPTBN5 PHLDB1 UBA1 PKD1 PLEC GTPBP3 DNHD1 LMNB2 CCT6A INA CROCC PCNT | 2.42e-06 | 253 | 208 | 13 | int:GAN |
| Interaction | DISC1 interactions | SPTBN1 RNF40 ZNF318 PFKL SYNM LENG1 CAPZA1 PPFIA3 CIT RASSF7 SPTBN4 KIFAP3 MACF1 PBXIP1 PCM1 PCNT TEDC1 | 2.46e-06 | 429 | 208 | 17 | int:DISC1 |
| Interaction | AR interactions | EPPK1 RNF40 ZNF318 RAD54L2 PTK6 RPRD1B FANCG ABCD3 GNAI3 MAGED1 KRT18 CAPZA1 CAPZA2 NUMA1 CHD8 CHD7 IPO4 GADD45GIP1 KANSL3 KIFAP3 CCT6A TKFC SUGP2 AP5B1 ELAVL1 PCM1 TEDC1 | 4.12e-06 | 992 | 208 | 27 | int:AR |
| Interaction | UBE2A interactions | FAM184B JPH4 SPTBN2 RNF40 UBA1 ABCD3 GNAI3 BCAR3 CCT6A ELAVL1 UBR3 ARHGEF2 | 4.25e-06 | 226 | 208 | 12 | int:UBE2A |
| Interaction | YWHAG interactions | CDK16 SPTBN1 LYST TAOK2 PHLDB1 UBA1 DLG4 JAKMIP1 TSC22D4 AMOTL2 NOTCH2 JCAD LNX2 KRT18 TNIP2 SHROOM2 RASSF7 GSS LRCH3 LPIN3 PPP1R3D CCDC88C VPS13D IGF1R INA ELAVL1 MACF1 NUB1 ARHGEF2 PCM1 NOS1AP | 4.89e-06 | 1248 | 208 | 31 | int:YWHAG |
| Interaction | YWHAE interactions | PRPSAP2 CDK16 PARD6G LYST TAOK2 PHLDB1 UBA1 KCNH2 DDX54 DLG4 JAKMIP1 AMOTL2 GOLGA3 JCAD KRT18 TNIP2 CAPZA1 CAPZA2 SHROOM2 GSS LRCH3 LPIN3 PPP1R3D CCDC88C IGF1R INA MACF1 NUB1 ARHGEF2 ZNF839 PCM1 | 5.56e-06 | 1256 | 208 | 31 | int:YWHAE |
| Interaction | HTT interactions | HSP90B1 EPPK1 DIS3L2 HK1 SPTB SPTBN1 SNX21 PFKL DLG4 GNAI3 PLEC PML POLR1C CAPZA1 CAPZA2 HIP1R GRIK5 LMNB2 PPFIA3 IPO4 CCT6A IGF1R INA HGS NUB1 ARHGEF2 | 5.61e-06 | 949 | 208 | 26 | int:HTT |
| Interaction | SPTA1 interactions | 5.86e-06 | 94 | 208 | 8 | int:SPTA1 | |
| Interaction | SCARB2 interactions | HK1 SPTBN1 SPTBN2 DDX54 ABCD3 KRT18 POLR1C CAPZA1 NUMA1 LRCH3 PCM1 | 6.05e-06 | 195 | 208 | 11 | int:SCARB2 |
| Interaction | KALRN interactions | 6.86e-06 | 96 | 208 | 8 | int:KALRN | |
| Interaction | KRT19 interactions | FANCG PLEC AMOTL2 KRT18 SYNM TNIP2 LENG1 POLR1C INA HGS TNF PCM1 PCNT | 7.88e-06 | 282 | 208 | 13 | int:KRT19 |
| Interaction | KRT27 interactions | EPPK1 HSPBP1 CCDC88B GOLGA3 TNIP2 GADD45GIP1 IGF1R INA HGS CCDC68 CFAP58 | 8.46e-06 | 202 | 208 | 11 | int:KRT27 |
| Interaction | CDKL2 interactions | 8.57e-06 | 71 | 208 | 7 | int:CDKL2 | |
| Interaction | SIRT7 interactions | EPPK1 HK1 SPTBN1 SPTBN2 ZNF318 DDX54 NCAPD2 PLEC NOP2 MAGED1 NUMA1 CHD8 CHD7 LMNB2 IPO4 INA NUP155 SUGP2 ELAVL1 MACF1 PCM1 PCNT | 9.64e-06 | 744 | 208 | 22 | int:SIRT7 |
| Interaction | WASHC3 interactions | 1.07e-05 | 134 | 208 | 9 | int:WASHC3 | |
| Interaction | WDR76 interactions | HSP90B1 EPPK1 SPTBN1 RPRD1B UBA1 MACROH2A2 PLEC KRT18 POLR1C CAPZA2 NUMA1 LAMB2 CHD8 CHD7 CCT6A | 1.12e-05 | 383 | 208 | 15 | int:WDR76 |
| Interaction | TMPRSS2 interactions | HSP90B1 EPPK1 SPTB SPTBN2 DPM3 PFKL ITGAV GNAI3 GOLGA3 LMNB2 IPO4 IGF1R HGS TNF | 1.15e-05 | 337 | 208 | 14 | int:TMPRSS2 |
| Interaction | GBE1 interactions | 1.24e-05 | 75 | 208 | 7 | int:GBE1 | |
| Interaction | ECT2 interactions | HSP90B1 EPPK1 SPTB SPTBN1 SPTBN2 LYST NCAPD2 ABCD3 MACROH2A2 GNAI3 PLEC NOP2 PML CAPZA1 CAPZA2 NUMA1 CIT TRIM7 SPTBN4 INA NUP155 ELAVL1 MACF1 NUB1 | 1.62e-05 | 887 | 208 | 24 | int:ECT2 |
| Interaction | CUL7 interactions | HSP90B1 EPPK1 PFKL SPTBN5 UBA1 MACROH2A2 PLCB3 PLEC DOCK6 NOP2 GOLGA3 KRT18 CAPZA1 CAPZA2 NUMA1 LMNB2 CIT CCT6A INA NUP155 ELAVL1 MACF1 ZNF839 | 2.25e-05 | 845 | 208 | 23 | int:CUL7 |
| Interaction | SH3KBP1 interactions | CDK16 IRF2BP1 CCDC88B MAP3K4 PHLDB1 PIK3CA DLG4 TNIP2 CAPZA1 CAPZA2 HIP1R HGS ELAVL1 | 2.54e-05 | 315 | 208 | 13 | int:SH3KBP1 |
| Interaction | PPP1R9B interactions | HSP90B1 HK1 SPTB SPTBN1 SPTBN2 PFKL TAOK2 UBA1 DLG4 PLEC ANK2 CAPZA2 HIP1R LAMB2 ARHGAP9 INA CCDC68 ARHGEF2 PCM1 | 2.82e-05 | 626 | 208 | 19 | int:PPP1R9B |
| Interaction | NUPR1 interactions | SPTBN1 PFKL RPRD1B MACROH2A2 GNAI3 PLEC NOP2 PML KRT18 POLR1C CAPZA1 CAPZA2 NUMA1 LMNB2 CIT NUP155 ELAVL1 MACF1 PCM1 NOS1AP | 2.87e-05 | 683 | 208 | 20 | int:NUPR1 |
| Interaction | SNW1 interactions | HSP90B1 EPPK1 SPTBN1 HSPBP1 PFKL UBA1 NCAPD2 PLEC NOTCH1 PML TNIP2 CAPZA1 HIP1R CHD8 CHD7 CIT CCT6A NUP155 ELAVL1 ARHGEF2 SLX4 | 3.27e-05 | 747 | 208 | 21 | int:SNW1 |
| Interaction | TXNDC11 interactions | 4.38e-05 | 91 | 208 | 7 | int:TXNDC11 | |
| Interaction | SUMO2 interactions | HSP90B1 EPPK1 SPTBN1 PFKL RAD54L2 RPRD1B UBA1 NCAPD2 PLEC NOP2 PML ANKRD35 NUMA1 CHD8 NPEPL1 CCT6A ELAVL1 SLX4 | 4.41e-05 | 591 | 208 | 18 | int:SUMO2 |
| Interaction | TERF2 interactions | HSP90B1 RNF40 PFKL RPRD1B ZGPAT PML NUMA1 CHD8 CHD7 ELAVL1 MACF1 SLX4 PCM1 | 5.58e-05 | 340 | 208 | 13 | int:TERF2 |
| Interaction | CNTROB interactions | 5.85e-05 | 166 | 208 | 9 | int:CNTROB | |
| Interaction | CALM3 interactions | SPTBN1 ABCD3 PLCB3 PML TNIP2 CAPZA1 CAPZA2 GADD45GIP1 LRCH3 IGF1R ELAVL1 TNF PCNT | 6.10e-05 | 343 | 208 | 13 | int:CALM3 |
| Interaction | SYNE3 interactions | HSP90B1 ZNF318 TAOK2 PLEC NOTCH2 JCAD ERO1B SYNM MIB2 INA NUP155 HGS MACF1 PBXIP1 PCNT | 6.18e-05 | 444 | 208 | 15 | int:SYNE3 |
| Interaction | DCPS interactions | PFKL RPRD1B DDX54 GNAI3 PLEC NOP2 GOLGA3 FERMT3 PML LMNB2 GSS LRCH3 ELAVL1 PCNT | 6.38e-05 | 394 | 208 | 14 | int:DCPS |
| Interaction | DOCK7 interactions | PRPSAP2 UBA1 DOCK6 TNIP2 CAPZA1 CAPZA2 RASSF10 LRCH3 NUP155 SKAP1 ARHGEF2 | 6.99e-05 | 254 | 208 | 11 | int:DOCK7 |
| Interaction | WDR5 interactions | HSP90B1 EPPK1 SPTBN1 PFKL ZGPAT PIK3CA DDX54 GNAI3 PLEC NOP2 GOLGA3 PML KRT18 HIP1R CHD8 CHD7 LMNB2 IPO4 CIT KANSL3 CCT6A TKFC NUP155 MACF1 ARHGEF2 SLX4 | 7.12e-05 | 1101 | 208 | 26 | int:WDR5 |
| Interaction | KRT38 interactions | 7.69e-05 | 172 | 208 | 9 | int:KRT38 | |
| Interaction | CCDC183 interactions | 8.74e-05 | 44 | 208 | 5 | int:CCDC183 | |
| Interaction | SYNGAP1 interactions | SPTBN1 SPTBN2 TAOK2 ABCD3 DLG4 LNX2 ANK2 FAAP100 SUGP2 ARHGEF2 NOS1AP PCNT | 8.77e-05 | 307 | 208 | 12 | int:SYNGAP1 |
| Interaction | TSGA10IP interactions | 1.05e-04 | 140 | 208 | 8 | int:TSGA10IP | |
| Interaction | RAC1 interactions | PRPSAP2 SPTBN1 SPTBN2 PARD6G HSPBP1 ITGAV MAP3K4 PIK3CA DLG4 PLCB3 DOCK6 NOTCH1 NOTCH2 ARHGAP9 LMNB2 IPO4 CIT LRCH3 PRMT6 ARHGEF40 NUP155 MACF1 TNF ARHGEF2 STX10 | 1.06e-04 | 1063 | 208 | 25 | int:RAC1 |
| Interaction | HIF1AN interactions | ZGPAT UBA1 NFKBIB ABCD3 TLN2 NOTCH1 NOTCH2 ANK2 MIB2 CCT6A ELAVL1 ANKS3 | 1.19e-04 | 317 | 208 | 12 | int:HIF1AN |
| Interaction | FAM184B interactions | 1.23e-04 | 10 | 208 | 3 | int:FAM184B | |
| Interaction | KRT86 interactions | 1.25e-04 | 75 | 208 | 6 | int:KRT86 | |
| Interaction | EGFL7 interactions | 1.45e-04 | 77 | 208 | 6 | int:EGFL7 | |
| Interaction | KLC3 interactions | 1.46e-04 | 110 | 208 | 7 | int:KLC3 | |
| Interaction | SOX2 interactions | HK1 IRF2BP1 SPTB SPTBN1 SPTBN2 EVPL PFKL UBA1 CROCC2 NCAPD2 ABCD3 GNAI3 AMOTL2 NOP2 MAGED1 CAPZA1 NUMA1 HIP1R CHD8 CHD7 LMNB2 IPO4 CIT CCT6A ARHGEF40 SUGP2 ELAVL1 MACF1 NUB1 PCNT | 1.46e-04 | 1422 | 208 | 30 | int:SOX2 |
| Interaction | PLEKHA5 interactions | CDK16 SPTBN1 EVPL CCDC88B PLEC TNIP2 LAMB2 IGF1R ELAVL1 ARHGEF2 | 1.50e-04 | 231 | 208 | 10 | int:PLEKHA5 |
| Interaction | CLTC interactions | HSP90B1 SPTBN1 UBA1 PIK3CA DLG4 KRT18 TNIP2 CAPZA1 CAPZA2 HIP1R CIT CCT6A IGF1R HGS TNF ARHGEF2 SLX4 PCM1 | 1.62e-04 | 655 | 208 | 18 | int:CLTC |
| Interaction | ATG16L1 interactions | HSP90B1 ZGPAT PHLDB1 UBA1 DEDD2 NFKBIB PKD1 DDX54 GNAI3 PLEC NOP2 GOLGA3 FERMT3 MAGED1 CAPZA1 CAPZA2 IPO4 PDCD7 SHROOM2 LRCH3 PRMT6 ARHGEF40 ELAVL1 ARHGEF2 STX10 PCM1 | 1.67e-04 | 1161 | 208 | 26 | int:ATG16L1 |
| Interaction | CCDC42 interactions | 1.68e-04 | 11 | 208 | 3 | int:CCDC42 | |
| Interaction | TNIK interactions | SPTBN1 SPTBN2 TAOK2 DLG4 ANK2 CHD8 LMNB2 CIT INA MACF1 ARHGEF2 UNC13A PCM1 | 1.74e-04 | 381 | 208 | 13 | int:TNIK |
| Interaction | KRT14 interactions | 1.77e-04 | 192 | 208 | 9 | int:KRT14 | |
| Interaction | NPHP4 interactions | HSP90B1 EPPK1 SPTBN1 PARD6G PKD1 PLEC SMTN ANGPTL6 VPS13D SKAP1 | 1.78e-04 | 236 | 208 | 10 | int:NPHP4 |
| Interaction | PAK5 interactions | 1.93e-04 | 115 | 208 | 7 | int:PAK5 | |
| Interaction | RGS14 interactions | SPTB SPTBN1 SPTBN2 DLG4 GNAI3 TSC22D4 ANK2 CAPZA1 CAPZA2 UNC13A | 2.04e-04 | 240 | 208 | 10 | int:RGS14 |
| Interaction | H2AP interactions | 2.05e-04 | 82 | 208 | 6 | int:H2AP | |
| Interaction | TBCK interactions | 2.05e-04 | 82 | 208 | 6 | int:TBCK | |
| Interaction | LATS2 interactions | HSPBP1 NCAPD2 AMOTL2 NOTCH1 NOTCH2 JCAD LNX2 CIT CCDC88C ELAVL1 PCM1 | 2.17e-04 | 289 | 208 | 11 | int:LATS2 |
| Interaction | BRCA1 interactions | CDK16 HSP90B1 SPTBN1 PFKL RAD54L2 RPRD1B FANCG UBA1 DDX54 PLEC NOP2 PML DNHD1 ERO1B KRT18 CAPZA1 NUMA1 TSEN54 FAAP100 CIT ITIH5 SMTN GOLGA8DP CCT6A NUP155 HSPA14 SLX4 | 2.20e-04 | 1249 | 208 | 27 | int:BRCA1 |
| Interaction | GOLGA2 interactions | ZNF318 ZGPAT FANCG DDX54 DLG4 TSC22D4 AMOTL2 GOLGA3 NOTCH1 KRT18 LENG1 LMNB2 GADD45GIP1 TKFC NUP155 SUGP2 HGS CCDC17 PCM1 | 2.24e-04 | 733 | 208 | 19 | int:GOLGA2 |
| Interaction | PEX5L interactions | 2.34e-04 | 54 | 208 | 5 | int:PEX5L | |
| Interaction | WHAMMP3 interactions | 2.38e-04 | 119 | 208 | 7 | int:WHAMMP3 | |
| Interaction | LYZL2 interactions | 2.50e-04 | 85 | 208 | 6 | int:LYZL2 | |
| Interaction | KRT31 interactions | MXD3 EPPK1 ABI3 ZGPAT AMOTL2 TNIP2 LENG1 TSEN54 FAAP100 GADD45GIP1 INA HGS CCDC17 TEDC1 | 2.73e-04 | 453 | 208 | 14 | int:KRT31 |
| Interaction | PRPH interactions | 2.79e-04 | 204 | 208 | 9 | int:PRPH | |
| Interaction | GPSM2 interactions | 2.79e-04 | 31 | 208 | 4 | int:GPSM2 | |
| Interaction | P4HA1 interactions | HSP90B1 HK1 EVPL DLG4 TSC22D4 TNIP2 PDCD7 CIT ARHGEF40 IGF1R ELAVL1 | 2.83e-04 | 298 | 208 | 11 | int:P4HA1 |
| Interaction | SIRT6 interactions | RNF40 ZNF318 MAP3K4 RPRD1B DDX54 NCAPD2 ABCD3 MIOS NOP2 PML CAPZA1 NUMA1 CHD8 LRCH3 NUP155 ARHGEF2 SLX4 | 2.93e-04 | 628 | 208 | 17 | int:SIRT6 |
| Interaction | GOLGA6A interactions | 3.02e-04 | 57 | 208 | 5 | int:GOLGA6A | |
| Interaction | CTNNB1 interactions | HSP90B1 FANCG PIK3CA PKD1 ABCD3 DLG4 SLC30A9 NOTCH1 PML ANKRD35 JCAD ANK2 POLR1C CAPZA1 CAPZA2 NUMA1 CHD8 CIT CCDC88C KIFAP3 IGF1R ELAVL1 CROCC | 3.17e-04 | 1009 | 208 | 23 | int:CTNNB1 |
| Interaction | KPNA2 interactions | UBA1 NFKBIB NCAPD2 TSC22D4 MAGED1 KRT18 POLR1C NUMA1 LAMB2 ARHGAP9 CHD8 CIT KIFAP3 NUP155 SLX4 | 3.38e-04 | 519 | 208 | 15 | int:KPNA2 |
| Interaction | TNIP1 interactions | HSP90B1 EPPK1 SPTBN1 SPTBN2 PFKL DDX54 ABCD3 GNAI3 PLEC BCAR3 NOP2 KRT18 TNIP2 CAPZA1 CAPZA2 NUMA1 LAMA4 LAMB2 LRCH3 SMTN CCT6A NUP155 ELAVL1 TNF ARHGEF2 PCM1 | 3.47e-04 | 1217 | 208 | 26 | int:TNIP1 |
| Interaction | KRT39 interactions | 3.55e-04 | 59 | 208 | 5 | int:KRT39 | |
| Interaction | IGSF5 interactions | 3.63e-04 | 14 | 208 | 3 | int:IGSF5 | |
| Interaction | LFNG interactions | 3.63e-04 | 14 | 208 | 3 | int:LFNG | |
| Interaction | EGLN3 interactions | DPM3 RNF40 ZNF318 HSPBP1 RAD54L2 TAOK2 ZGPAT PHLDB1 ABCD3 MIOS GNAI3 SLC30A9 NOTCH2 PML JCAD MAGED1 POLR1C CAPZA1 CAPZA2 CHD8 PDCD2L IPO4 LRCH3 CCT6A NUB1 SLX4 PCM1 | 3.94e-04 | 1296 | 208 | 27 | int:EGLN3 |
| Interaction | KIF23 interactions | HSP90B1 EPPK1 SPTBN1 PFKL MAP3K4 ABCD3 MACROH2A2 GNAI3 TTC22 PLEC NOP2 AMH POLR1C CAPZA2 LAMA2 LMNB2 CIT NUP155 SUGP2 ELAVL1 MACF1 ARHGEF2 SLX4 | 4.28e-04 | 1031 | 208 | 23 | int:KIF23 |
| Interaction | TSC1 interactions | CCDC88B PHLDB1 DLG4 ANKRD35 MAGED1 LENG1 PRMT6 IGF1R NUP155 HGS ARHGEF2 PCM1 | 4.42e-04 | 366 | 208 | 12 | int:TSC1 |
| Interaction | CACNG8 interactions | 4.50e-04 | 15 | 208 | 3 | int:CACNG8 | |
| Interaction | CEP57L1 interactions | 4.56e-04 | 95 | 208 | 6 | int:CEP57L1 | |
| Cytoband | 20q13.3 | 1.04e-04 | 20 | 212 | 3 | 20q13.3 | |
| Cytoband | 16p13.3 | 1.51e-04 | 244 | 212 | 7 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | MBD3L1 REEP6 GTPBP3 DOCK6 AMH LMNB2 GADD45GIP1 ANGPTL6 SUGP2 ELAVL1 STX10 UNC13A | 3.69e-04 | 797 | 212 | 12 | chr19p13 |
| Cytoband | 19p13.2 | 7.22e-04 | 229 | 212 | 6 | 19p13.2 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.26e-10 | 7 | 118 | 5 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.18e-07 | 8 | 118 | 4 | 939 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD63 NFKBIB NOTCH1 NOTCH2 ESPN ANKRD35 ASZ1 ANK2 MIB2 ANKS3 | 4.22e-06 | 242 | 118 | 10 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTB SPTBN1 SPTBN2 PHLDB1 FERMT3 ARHGAP9 SPTBN4 SKAP1 ARHGEF2 | 8.32e-06 | 206 | 118 | 9 | 682 |
| GeneFamily | Laminin subunits | 5.71e-05 | 12 | 118 | 3 | 626 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 4.17e-04 | 5 | 118 | 2 | 1199 | |
| GeneFamily | Intermediate filaments Type IV | 6.23e-04 | 6 | 118 | 2 | 611 | |
| GeneFamily | Ras association domain family | 1.84e-03 | 10 | 118 | 2 | 1198 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | LRRC45 KCNH2 DEDD2 PML SZT2 LENG1 CIT CCDC88C SUGP2 PBXIP1 TEDC1 | 7.29e-07 | 200 | 211 | 11 | M6208 |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-08 | 175 | 212 | 10 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.84e-07 | 186 | 212 | 9 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PRPSAP2 ABI3 PFKL TSC22D4 FERMT3 CAPZA1 CAPZA2 ELAVL1 ARHGEF2 | 4.60e-07 | 197 | 212 | 9 | 173c0c8de4e69882a9f91189deeb4a651fefe551 |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-06 | 114 | 212 | 7 | 670c9802a59b39241abf6f2c12a3d1844c7db5e5 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-06 | 166 | 212 | 8 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.70e-06 | 182 | 212 | 8 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-06 | 182 | 212 | 8 | 27a27a3eaeacb087c9601d5bb1c9e57cdfcd9d77 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-06 | 190 | 212 | 8 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-06 | 190 | 212 | 8 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-06 | 190 | 212 | 8 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 4.16e-06 | 193 | 212 | 8 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 4.16e-06 | 193 | 212 | 8 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.49e-06 | 195 | 212 | 8 | 14a6466524c22920daa622fbc710daf1defb46c3 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 196 | 212 | 8 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 196 | 212 | 8 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Brain_Myeloid-Cortex_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 197 | 212 | 8 | 81379fe6bd14a1ba26f4a159497262adcb600b18 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 197 | 212 | 8 | 271c75f491d03bd248c7ec037ef02e39456f3ac0 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 197 | 212 | 8 | e73ca8c8f42cbcc56eaa5fe3d69abd1ce7b7bbca | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 197 | 212 | 8 | 9db329c6fea532dd1afb624f4c29c92407f45568 | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.41e-06 | 200 | 212 | 8 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 5.41e-06 | 200 | 212 | 8 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-05 | 160 | 212 | 7 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 163 | 212 | 7 | 9c91415a56b12b3b2d15d253bb59db8bedf49ea2 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.62e-05 | 168 | 212 | 7 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 169 | 212 | 7 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.82e-05 | 171 | 212 | 7 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | Control-Lymphocyte-T_NK-gdT|Control / Disease, Lineage and Cell Type | 2.04e-05 | 174 | 212 | 7 | 202d222a53f967cce172e5f3f1b40920ea13ec6c | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 175 | 212 | 7 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 175 | 212 | 7 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 179 | 212 | 7 | 06f92c884189197c86793191c05f65e34925c097 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-05 | 181 | 212 | 7 | cfc3ed541d93158ce26641ea30b7573d93600a11 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 181 | 212 | 7 | 064057ab36c6d92c36572b73142b42d201709d7b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 183 | 212 | 7 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.91e-05 | 184 | 212 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 185 | 212 | 7 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 185 | 212 | 7 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.12e-05 | 186 | 212 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-05 | 188 | 212 | 7 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 188 | 212 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-05 | 189 | 212 | 7 | 8478f433495dabe813146a1f6b00098db8ce775a | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.46e-05 | 189 | 212 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 190 | 212 | 7 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 190 | 212 | 7 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.58e-05 | 190 | 212 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 190 | 212 | 7 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 191 | 212 | 7 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.70e-05 | 191 | 212 | 7 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.82e-05 | 192 | 212 | 7 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 193 | 212 | 7 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 193 | 212 | 7 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 193 | 212 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 3.95e-05 | 193 | 212 | 7 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 193 | 212 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 193 | 212 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-05 | 194 | 212 | 7 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 194 | 212 | 7 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-05 | 194 | 212 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-05 | 194 | 212 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 4.22e-05 | 195 | 212 | 7 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | PSB-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.22e-05 | 195 | 212 | 7 | e585d264dec3010134bb6aecbed85b2256f23c79 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-05 | 196 | 212 | 7 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.36e-05 | 196 | 212 | 7 | 511e9846d204b2346b17d1a4142c3bb484b08e32 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-05 | 197 | 212 | 7 | 0e93800d5df652a9c691c66a3f75a2e8979aed8e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-05 | 197 | 212 | 7 | 35004d4728d33f15cc3be99a073b1ea965365c32 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.50e-05 | 197 | 212 | 7 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-05 | 198 | 212 | 7 | e67488695ce5e32ed8d149ed0b841540cbfdd3e2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-05 | 198 | 212 | 7 | 7696f042648bd53c0a019dfeea68808aa5898615 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.79e-05 | 199 | 212 | 7 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-05 | 199 | 212 | 7 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-05 | 200 | 212 | 7 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.95e-05 | 200 | 212 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-05 | 149 | 212 | 6 | 34a3075af794052763fc7c4135f3031f89da5caa | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-05 | 149 | 212 | 6 | 183c77cc8f23b8406e7241a066cb684470002a3b | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-05 | 149 | 212 | 6 | 406a5ccfedbf43543f0346ff7ef3ce1d15c38f29 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-05 | 149 | 212 | 6 | be698ecce34ddbdf57d08082b71268934675e74e | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.61e-05 | 151 | 212 | 6 | 75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.92e-05 | 152 | 212 | 6 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.10e-05 | 95 | 212 | 5 | ef0b7289b348617a76b4643479adc7e9701c0094 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.10e-05 | 95 | 212 | 5 | 8b4d6b25ce28811a76ea11713d881117e495ef5e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.10e-05 | 95 | 212 | 5 | 53dde5363ea1d64386234e5bd4fbb28c057f2f21 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.59e-05 | 154 | 212 | 6 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 1.03e-04 | 156 | 212 | 6 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.03e-04 | 156 | 212 | 6 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 1.07e-04 | 157 | 212 | 6 | d85304af4cd3b8aaedc5362a8223537e1b9dbec2 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 161 | 212 | 6 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.27e-04 | 162 | 212 | 6 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 1.31e-04 | 163 | 212 | 6 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-04 | 164 | 212 | 6 | ea02ca343b2b28e437304de889e2ae1e315a1197 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-04 | 166 | 212 | 6 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 1.45e-04 | 166 | 212 | 6 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-04 | 167 | 212 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 168 | 212 | 6 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 168 | 212 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | MXD3 CDK16 SPTBN2 PTK6 TAOK2 PHLDB1 TLN2 TSC22D4 NOTCH1 FBXL15 APLP1 CHD7 PPP1R3D VPS13D PBXIP1 | 2.11e-10 | 185 | 211 | 15 | 4327_DN |
| Drug | plakin | 6.94e-08 | 82 | 211 | 9 | CID000018752 | |
| Drug | ADPribulose | 7.90e-08 | 13 | 211 | 5 | CID000197570 | |
| Drug | PRODAN | 1.82e-07 | 15 | 211 | 5 | CID000028127 | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | PTK6 TAOK2 KCNH2 CLEC11A NFKBIB PLCB3 TSC22D4 NOTCH2 NPEPL1 SMTN CCDC88C VPS13D | 2.81e-07 | 194 | 211 | 12 | 3193_DN |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | MXD3 TBC1D9B ZNF318 LYST DDX54 DOCK6 PML C14orf93 NUMA1 APLP1 SMTN PCM1 | 3.14e-07 | 196 | 211 | 12 | 3272_DN |
| Drug | MDL 28170 | 6.51e-07 | 54 | 211 | 7 | CID000072430 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | MXD3 DELE1 NFKBIB PML C14orf93 SZT2 PPFIA3 PPP1R3D VPS13D PBXIP1 NOS1AP | 2.09e-06 | 194 | 211 | 11 | 1001_UP |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | RNF40 DELE1 TSC22D4 DOCK6 PML SZT2 FBXL15 SHROOM2 NPEPL1 TENM1 PBXIP1 | 2.09e-06 | 194 | 211 | 11 | 4559_DN |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | KCNH2 NFKBIB PLCB3 NOTCH2 PML NUMA1 NPEPL1 CCDC88C VPS13D TENM1 PCM1 | 2.20e-06 | 195 | 211 | 11 | 5744_DN |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | CDK16 LYST PTK6 NFKBIB DDX54 PLEC PML APLP1 PPFIA3 SMTN PCM1 | 2.55e-06 | 198 | 211 | 11 | 3246_DN |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A | SPTBN1 MAP3K4 PHLDB1 DDX54 KCNS1 PLCB3 GNAI3 PLEC DOCK6 APLP1 SMTN | 2.55e-06 | 198 | 211 | 11 | 3439_UP |
| Drug | 4-methyleneglutamic acid | 3.12e-06 | 4 | 211 | 3 | CID000096407 | |
| Drug | Coomassie blue | 4.85e-06 | 135 | 211 | 9 | CID000019731 | |
| Drug | tetrathionate | 5.92e-06 | 49 | 211 | 6 | CID000026259 | |
| Drug | dimethyl adipimidate | 7.69e-06 | 30 | 211 | 5 | CID000025738 | |
| Drug | AC1L1KMJ | SPTB SPTBN1 SPTBN2 MC1R SPTBN5 PIK3CA PKD1 DLG4 PLEC ESPN ANK2 LAMA2 LAMA4 LAMB2 SPTBN4 MACF1 | 1.02e-05 | 476 | 211 | 16 | CID000030956 |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 1.20e-05 | 16 | 211 | 4 | CID000107729 | |
| Drug | MAPS | 1.23e-05 | 191 | 211 | 10 | CID000066161 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 1.35e-05 | 193 | 211 | 10 | 1647_UP | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | TBC1D9B RAD54L2 PHLDB1 DDX54 PLCB3 DOCK6 PPFIA3 RASSF7 SMTN SUGP2 | 1.41e-05 | 194 | 211 | 10 | 1480_DN |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | TBC1D9B SPTBN2 PHLDB1 NOTCH1 PML JCAD NUMA1 PPFIA3 NPEPL1 VPS13D | 1.48e-05 | 195 | 211 | 10 | 7559_UP |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | RAD54L2 TSC22D4 PML NRL NUMA1 LAMA4 KANSL3 VPS13D SUGP2 CTF1 | 1.48e-05 | 195 | 211 | 10 | 2897_UP |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | CDK16 EPPK1 IRF2BP1 DELE1 MAP3K4 TAOK2 PLCB3 GTPBP3 FBXL15 PBXIP1 | 1.54e-05 | 196 | 211 | 10 | 5288_UP |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | IRF2BP1 SPTBN2 CLEC11A DOCK6 LAMA2 LAMA4 PPP1R3D VPS13D CROCC PCM1 | 1.54e-05 | 196 | 211 | 10 | 3790_DN |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | CDK16 TBC1D9B ZNF318 TLN2 NOTCH1 NOTCH2 C14orf93 VPS13D ZNF839 PCM1 | 1.54e-05 | 196 | 211 | 10 | 4594_DN |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | CDK16 HSP90B1 EPPK1 LYST PLCB3 PLEC TBCC FBXL15 PPFIA3 IGF1R | 1.54e-05 | 196 | 211 | 10 | 7087_DN |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | IRF2BP1 CLEC11A MACROH2A2 PLCB3 PLEC DOCK6 PPFIA3 VPS13D ELAVL1 MACF1 | 1.61e-05 | 197 | 211 | 10 | 4774_DN |
| Drug | LY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A | CDK16 SPTBN1 ZGPAT ALPK3 KCNS1 PML NPEPL1 PPP1R3D TKFC UNC13A | 1.61e-05 | 197 | 211 | 10 | 1216_UP |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | CLEC11A NFKBIB ALPK3 TLN2 TSC22D4 FKRP NUMA1 GRIK5 FAAP100 VPS13D | 1.69e-05 | 198 | 211 | 10 | 3730_DN |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.69e-05 | 198 | 211 | 10 | 2901_UP | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A | MXD3 HSP90B1 EVPL ZNF318 PTK6 FBXL15 SMTN ZNF839 PBXIP1 PCM1 | 1.69e-05 | 198 | 211 | 10 | 5338_DN |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | MXD3 SPTBN1 SPTBN2 PLEC SZT2 FBXL15 PPFIA3 IGF1R ARHGEF2 ZNF839 | 1.69e-05 | 198 | 211 | 10 | 6603_DN |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; PC3; HT_HG-U133A | MXD3 TBC1D9B PHLDB1 DDX54 PLCB3 NUMA1 HIP1R PPFIA3 IGF1R PBXIP1 | 1.69e-05 | 198 | 211 | 10 | 7296_DN |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | IRF2BP1 PHLDB1 TLN2 NOTCH2 LAMA4 SHROOM2 NPEPL1 ARHGEF40 ZNF839 PCM1 | 1.69e-05 | 198 | 211 | 10 | 7380_UP |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | MXD3 SPTBN2 ZNF318 PHLDB1 KCNH2 NOTCH2 PML APLP1 PPFIA3 SUGP2 | 1.69e-05 | 198 | 211 | 10 | 3326_DN |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.69e-05 | 198 | 211 | 10 | 4320_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A | 1.69e-05 | 198 | 211 | 10 | 1299_DN | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 1.76e-05 | 199 | 211 | 10 | 1229_UP | |
| Drug | Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A | EVPL DELE1 TAOK2 PHLDB1 PLCB3 NUMA1 FBXL15 FAAP100 RASSF7 PCM1 | 1.76e-05 | 199 | 211 | 10 | 7403_DN |
| Drug | Amoxapine [14028-44-5]; Up 200; 12.8uM; PC3; HG-U133A | TBC1D9B DELE1 ZNF318 ZGPAT NOTCH2 HIP1R APLP1 FAAP100 INA PBXIP1 | 1.76e-05 | 199 | 211 | 10 | 1931_UP |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | CDK16 EPPK1 EVPL RAD54L2 PTK6 PHLDB1 TSC22D4 NOTCH1 GRIK5 VPS13D | 1.84e-05 | 200 | 211 | 10 | 3322_UP |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A | CDK16 IRF2BP1 TAOK2 CLEC11A NFKBIB TSC22D4 DOCK6 NOTCH2 SMTN NOS1AP | 1.84e-05 | 200 | 211 | 10 | 3380_DN |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | PRPSAP2 MAP3K4 TLN2 GNAI3 ANK2 G0S2 PPFIA3 PPP1R3D IGF1R SUGP2 | 1.84e-05 | 200 | 211 | 10 | 1_DN |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 2.91e-05 | 211 | 211 | 10 | ctd:C009618 | |
| Drug | AC1L1HCM | 4.60e-05 | 22 | 211 | 4 | CID000004072 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 5.50e-05 | 183 | 211 | 9 | 5599_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 6.23e-05 | 186 | 211 | 9 | 5597_UP | |
| Drug | NS3763 | 6.33e-05 | 9 | 211 | 3 | CID004359312 | |
| Drug | oxypeucedanin | 6.33e-05 | 9 | 211 | 3 | CID000033306 | |
| Drug | Hexestrol [84-16-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 7.65e-05 | 191 | 211 | 9 | 6077_UP | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 8.07e-05 | 48 | 211 | 5 | CID000092266 | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | RAD54L2 NFKBIB PLCB3 PPFIA3 CCDC68 ARHGEF2 CROCC PCM1 NOS1AP | 8.28e-05 | 193 | 211 | 9 | 2829_UP |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 6895_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 4763_DN | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 4617_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 3303_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 5091_UP | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 5303_UP | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 7493_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | RAD54L2 PTK6 PHLDB1 PLCB3 PPFIA3 NPEPL1 VPS13D ARHGEF2 CROCC | 8.96e-05 | 195 | 211 | 9 | 6299_UP |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 6739_DN | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 6129_DN | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 5077_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 3941_DN | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 6662_DN | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 8.96e-05 | 195 | 211 | 9 | 630_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 3201_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 4124_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | 9.32e-05 | 196 | 211 | 9 | 2044_DN | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 2528_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A | 9.32e-05 | 196 | 211 | 9 | 203_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 5322_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 4296_DN | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A | HSP90B1 SPTBN1 CLEC11A KCNS1 NOTCH2 FKRP TENM1 ARHGEF2 UNC13A | 9.32e-05 | 196 | 211 | 9 | 4600_UP |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | IRF2BP1 SPTBN1 RAD54L2 CLEC11A NFKBIB DDX54 KCNS1 CROCC PCM1 | 9.32e-05 | 196 | 211 | 9 | 2232_DN |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 3881_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 7234_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 2884_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | MXD3 IRF2BP1 DELE1 NFKBIB MACROH2A2 NUMA1 FBXL15 NPEPL1 CCDC88C | 9.32e-05 | 196 | 211 | 9 | 7017_DN |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 2770_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 3176_DN | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 6099_UP | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 5528_UP | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | MXD3 RAD54L2 PTK6 PHLDB1 PLCB3 C14orf93 SHROOM2 ARHGEF40 PBXIP1 | 9.69e-05 | 197 | 211 | 9 | 6311_UP |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 2689_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 3365_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 7401_UP | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 5356_DN | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 6514_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 7309_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 6306_UP | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 6010_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 2768_DN | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | EPPK1 IRF2BP1 ZNF318 TLN2 NOTCH2 PPFIA3 PPP1R3D MACF1 PBXIP1 | 9.69e-05 | 197 | 211 | 9 | 5481_DN |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; HL60; HG-U133A | 9.69e-05 | 197 | 211 | 9 | 1429_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A | 1.01e-04 | 198 | 211 | 9 | 1997_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.01e-04 | 198 | 211 | 9 | 4498_DN | |
| Drug | iloprost; Up 200; 1uM; MCF7; HG-U133A | PRPSAP2 HSP90B1 MAP3K4 NUMA1 FBXL15 GRIK5 PPFIA3 VPS13D ADAMTS7 | 1.01e-04 | 198 | 211 | 9 | 488_UP |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.01e-04 | 198 | 211 | 9 | 5871_DN | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.18e-09 | 4 | 203 | 4 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Mouth Diseases | 6.74e-05 | 12 | 203 | 3 | C0026636 | |
| Disease | Developmental delay (disorder) | 1.20e-04 | 37 | 203 | 4 | C0424605 | |
| Disease | Romano-Ward Syndrome | 1.68e-04 | 16 | 203 | 3 | C0035828 | |
| Disease | Malignant neoplasm of breast | TBC1D9B ZNF318 PIK3CA BCAR3 TSC22D4 NOTCH1 NOTCH2 ANK2 KRT18 LAMA2 GRM6 SHROOM2 IGF1R INA ASL TENM1 MACF1 TNF HSPA14 | 1.70e-04 | 1074 | 203 | 19 | C0006142 |
| Disease | Bone marrow hypocellularity | 2.43e-04 | 18 | 203 | 3 | C1855710 | |
| Disease | sexual dimorphism measurement | FAM184B EPPK1 DIS3L2 RAD54L2 TAOK2 SPTBN5 ZGPAT KCNH2 PKD1 ALPK3 PLCB3 PLEC GSS ARHGEF40 IGF1R AP5B1 MACF1 CROCC ANKS3 | 2.46e-04 | 1106 | 203 | 19 | EFO_0021796 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.62e-04 | 49 | 203 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.89e-04 | 21 | 203 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | Schizophrenia | CDK16 HK1 SPTBN2 PIK3CA KCNH2 DLG4 PML LAMA2 GRIK4 GRIK5 PLA2G4B CCDC68 TNF PCM1 NOS1AP PCNT | 4.32e-04 | 883 | 203 | 16 | C0036341 |
| Disease | Cardiac Arrest | 4.65e-04 | 5 | 203 | 2 | C0018790 | |
| Disease | electrocardiography, QT interval | 4.65e-04 | 5 | 203 | 2 | EFO_0004327, EFO_0004682 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 6.60e-04 | 25 | 203 | 3 | EFO_0010556 | |
| Disease | Fanconi Anemia | 6.60e-04 | 25 | 203 | 3 | C0015625 | |
| Disease | Adams Oliver syndrome | 6.94e-04 | 6 | 203 | 2 | C0265268 | |
| Disease | Congenital defect of skull and scalp | 6.94e-04 | 6 | 203 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 6.94e-04 | 6 | 203 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 6.94e-04 | 6 | 203 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | cortical thickness | VWA5B2 SPTBN1 SPTBN2 ZNF318 PHLDB1 PKD1 PLEC POLR1C CAPZA1 RDH14 LAMA2 CHD7 ITIH5 VPS13D ARHGEF40 IGF1R ADAMTS7 MACF1 | 7.25e-04 | 1113 | 203 | 18 | EFO_0004840 |
| Disease | Pancytopenia | 7.42e-04 | 26 | 203 | 3 | C0030312 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 9.67e-04 | 7 | 203 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Visual Impairment | 9.67e-04 | 7 | 203 | 2 | C3665347 | |
| Disease | long QT syndrome (is_implicated_in) | 9.67e-04 | 7 | 203 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Solid Neoplasm | 9.67e-04 | 7 | 203 | 2 | C0280100 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 9.67e-04 | 7 | 203 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 9.67e-04 | 7 | 203 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | vascular dementia (is_implicated_in) | 9.67e-04 | 7 | 203 | 2 | DOID:8725 (is_implicated_in) | |
| Disease | acute promyelocytic leukemia (is_implicated_in) | 9.67e-04 | 7 | 203 | 2 | DOID:0060318 (is_implicated_in) | |
| Disease | L-Selectin measurement | 1.25e-03 | 31 | 203 | 3 | EFO_0008202 | |
| Disease | primary sclerosing cholangitis (is_marker_for) | 1.28e-03 | 8 | 203 | 2 | DOID:0060643 (is_marker_for) | |
| Disease | Muscular Dystrophies, Limb-Girdle | 1.37e-03 | 32 | 203 | 3 | C0686353 | |
| Disease | Squamous cell carcinoma of lung | 1.37e-03 | 32 | 203 | 3 | C0149782 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.64e-03 | 34 | 203 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | gamma-glutamylisoleucine measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0021139 | |
| Disease | Hydrocephalus | 1.64e-03 | 9 | 203 | 2 | C0020255 | |
| Disease | serum gamma-glutamyl transferase measurement | DPM3 NFKBIB PKD1 JAKMIP1 NOTCH2 JCAD AMH AMN CAPZA2 FAAP100 CIT PRMT6 IGF1R ARHGEF2 CD276 | 1.74e-03 | 914 | 203 | 15 | EFO_0004532 |
| Disease | mean platelet volume | SPTBN1 FANCG KCNS1 PLEC EXOC3L2 FERMT3 JCAD LNX2 PCDHGB5 CAPZA1 CAPZA2 NUMA1 HIP1R CHD7 CCDC68 NOS1AP | 1.94e-03 | 1020 | 203 | 16 | EFO_0004584 |
| Disease | Global developmental delay | 2.31e-03 | 133 | 203 | 5 | C0557874 | |
| Disease | Enzymopathy | 2.49e-03 | 11 | 203 | 2 | C0520572 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.82e-03 | 41 | 203 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.82e-03 | 41 | 203 | 3 | C0858252 | |
| Disease | Congenital small ears | 2.82e-03 | 41 | 203 | 3 | C0152423 | |
| Disease | Neurogenic Inflammation | 2.97e-03 | 12 | 203 | 2 | C0600467 | |
| Disease | Congenital muscular dystrophy | 2.97e-03 | 12 | 203 | 2 | cv:C0699743 | |
| Disease | left ventricular structural measurement | 3.23e-03 | 88 | 203 | 4 | EFO_0008205 | |
| Disease | descending aortic diameter | 3.23e-03 | 88 | 203 | 4 | EFO_0021788 | |
| Disease | Malignant Head and Neck Neoplasm | 3.45e-03 | 44 | 203 | 3 | C0278996 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 3.49e-03 | 13 | 203 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | Connective Tissue Diseases | 3.49e-03 | 13 | 203 | 2 | C0009782 | |
| Disease | obesity (implicated_via_orthology) | 3.84e-03 | 215 | 203 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | nephroblastoma (is_implicated_in) | 4.06e-03 | 14 | 203 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Fanconi anemia | 4.06e-03 | 14 | 203 | 2 | cv:C0015625 | |
| Disease | sickle cell anemia (is_marker_for) | 4.06e-03 | 14 | 203 | 2 | DOID:10923 (is_marker_for) | |
| Disease | T wave morphology measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0008398 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 4.06e-03 | 14 | 203 | 2 | cv:C2931907 | |
| Disease | Sarcoma, Spindle Cell | 4.06e-03 | 14 | 203 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 4.06e-03 | 14 | 203 | 2 | C0205944 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.10e-03 | 152 | 203 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Muscular Atrophy | 4.66e-03 | 15 | 203 | 2 | C0026846 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.66e-03 | 15 | 203 | 2 | C0496930 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 4.66e-03 | 15 | 203 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | gamma-glutamylphenylalanine measurement | 4.66e-03 | 15 | 203 | 2 | EFO_0021142 | |
| Disease | caffeine measurement | 4.66e-03 | 15 | 203 | 2 | EFO_0021177 | |
| Disease | Benign neoplasm of bladder | 4.66e-03 | 15 | 203 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.66e-03 | 15 | 203 | 2 | C0154091 | |
| Disease | Neurogenic Muscular Atrophy | 4.66e-03 | 15 | 203 | 2 | C0270948 | |
| Disease | white matter hyperintensity measurement | 5.08e-03 | 302 | 203 | 7 | EFO_0005665 | |
| Disease | cerebellum white matter volume change measurement | 5.30e-03 | 16 | 203 | 2 | EFO_0021498 | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.30e-03 | 16 | 203 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 5.30e-03 | 16 | 203 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Weight Gain | 5.47e-03 | 102 | 203 | 4 | C0043094 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 5.66e-03 | 103 | 203 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Tactile Amnesia | 5.98e-03 | 17 | 203 | 2 | C0750906 | |
| Disease | Amnestic State | 5.98e-03 | 17 | 203 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 5.98e-03 | 17 | 203 | 2 | C0236795 | |
| Disease | Vitiligo | 5.98e-03 | 17 | 203 | 2 | C0042900 | |
| Disease | muscular dystrophy (is_implicated_in) | 5.98e-03 | 17 | 203 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Hysterical amnesia | 5.98e-03 | 17 | 203 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 5.98e-03 | 17 | 203 | 2 | C0233796 | |
| Disease | Amnesia | 5.98e-03 | 17 | 203 | 2 | C0002622 | |
| Disease | Global Amnesia | 5.98e-03 | 17 | 203 | 2 | C0262497 | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 5.98e-03 | 17 | 203 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 6.05e-03 | 105 | 203 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Acute Cerebrovascular Accidents | 6.15e-03 | 54 | 203 | 3 | C0751956 | |
| Disease | Necrosis | 6.47e-03 | 55 | 203 | 3 | C0027540 | |
| Disease | cardioembolic stroke | 6.55e-03 | 170 | 203 | 5 | EFO_1001976 | |
| Disease | Anorexia | 6.70e-03 | 18 | 203 | 2 | C0003123 | |
| Disease | Carcinoma of bladder | 6.70e-03 | 18 | 203 | 2 | C0699885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVLQLRELAQRGSAA | 1636 | Q9UPW8 | |
| AVNISAARGLQDVLR | 21 | P40227 | |
| LGADERLRLAELNAQ | 96 | A6NGE7 | |
| QRRRAELLEQALGNA | 451 | Q9Y2J4 | |
| AGRLREDAAQLQRLF | 256 | Q2M3D2 | |
| GLRNTAARQEILAVA | 326 | Q2M3D2 | |
| LQAELQGAVRTNERL | 356 | O75150 | |
| QAELFLRLVNARDAA | 536 | Q96LX7 | |
| LRLVNARDAAVQTLA | 541 | Q96LX7 | |
| AEAIARARARGEQNI | 466 | Q9HCK8 | |
| VDSLAAVVLQNRRGL | 446 | Q9N2K0 | |
| AVVLQNRRGLDLLTA | 451 | Q9N2K0 | |
| VDSLAAVVLQNRRGL | 446 | Q9N2J8 | |
| LGAAVQLLREQEARG | 1236 | Q8TER5 | |
| LAQLQRRQEAELEGL | 1081 | A6NC98 | |
| ARQARALGAAVEALL | 126 | Q16619 | |
| SQIQEARADLARRGL | 76 | Q9P2X0 | |
| NLVQRDGDFLVRDSL | 166 | O75815 | |
| LKAQQRDVDGATLAR | 196 | Q16352 | |
| VRLLLNNDNLLREGA | 36 | P52907 | |
| REAEEARRQLAALGQ | 851 | Q92974 | |
| RQEIVALLNAFGRLS | 436 | Q86YB8 | |
| AQRRQALRQLDGELG | 171 | Q969Y2 | |
| LAAEILELAGNAARD | 56 | Q9P0M6 | |
| LDREVQAGRQALAAA | 1246 | Q96L96 | |
| IALINDQRRAALEGF | 381 | P51693 | |
| DQRRAALEGFLAALQ | 386 | P51693 | |
| LDEALQGSALRDQLR | 251 | Q17RM4 | |
| AGRLARALLADVAEN | 321 | Q9BXJ7 | |
| AIRGENARLALQLQD | 946 | Q8N283 | |
| DLLAQGNASLRLQRV | 316 | Q5ZPR3 | |
| GNASLRLQRVRVADE | 321 | Q5ZPR3 | |
| ARQLDVFGQATAVLR | 226 | Q8WXF8 | |
| RLLLALRGEAALDQN | 4591 | Q96M86 | |
| NDVLNQRDALGRVLV | 236 | Q9Y4B4 | |
| LQASREAGAAALRNV | 116 | Q9H2F9 | |
| EAGAAALRNVAQRLF | 121 | Q9H2F9 | |
| IDGVVARNRALNGDL | 96 | Q8IYB7 | |
| QENLEAAQLAGELAR | 361 | A6NI56 | |
| IDGRVRGNLRQAAID | 1336 | Q9P2D1 | |
| FRLTQGLQEALDRAD | 1171 | O14578 | |
| EAAVRELRQAQGALA | 251 | Q9HA90 | |
| ELRQAQGALAAAEAR | 256 | Q9HA90 | |
| NAELVRVLLDRGANA | 91 | Q8WWH4 | |
| RIQEVAEAANFLALR | 726 | Q9UKP4 | |
| FVRLLLEQGAAVNLR | 66 | C9JTQ0 | |
| ADIGILRNRIDQASL | 201 | Q5T7V8 | |
| RLQALDAQARALEAE | 206 | Q02833 | |
| AGEAQAAALEELARR | 311 | A6NK89 | |
| LRKELERVAGALQAQ | 311 | H3BPF8 | |
| LEAGALVARAAVLQQ | 101 | Q01726 | |
| LVAEAALRVFRGNVQ | 506 | Q9Y5A7 | |
| LDLQGAALRQVEARV | 76 | Q9P2A4 | |
| VNVATLLLNRGAAVD | 246 | Q01484 | |
| LLLNRGAAVDFTARN | 251 | Q01484 | |
| ERLAIALIADGLANE | 166 | Q8WWY6 | |
| EQLLQDARSFLRALG | 1556 | Q04721 | |
| IRRLNLQEGANDVVF | 601 | Q9BQK8 | |
| DNARIVLQIDNARLA | 146 | P05783 | |
| QIGNLEALRDLNVRR | 191 | Q96II8 | |
| ADAQGVFQILIRNRA | 1971 | P46531 | |
| QRQLEQLRGLAGAAE | 131 | Q9BW11 | |
| GAAQPRDVALLQERA | 461 | Q9Y5V3 | |
| AVNRTLEILDLRGNA | 971 | Q7RTR2 | |
| GEAARADDARQLFVL | 96 | P08754 | |
| TDINGALQRAIRLLN | 371 | Q86UX2 | |
| ALLARVQGRALQEGQ | 216 | Q96BZ8 | |
| RGLESDVAELRAQLA | 171 | Q03252 | |
| LREAQDGLATAQLRL | 46 | O75145 | |
| VDRELLRAELNFGAI | 211 | P04424 | |
| DILGSQLVRRNDELA | 611 | Q5T655 | |
| SLQARAARILGIEVA | 1081 | Q9P266 | |
| ALQAARQGELDVLRS | 6 | B1AK53 | |
| LEALQAELRALGRQQ | 751 | Q9ULE4 | |
| RRAAAQIAQALLGAE | 76 | Q12809 | |
| GDVESRLDALQRQLN | 1036 | Q12809 | |
| QRQEIAAARAADALL | 376 | Q96JJ6 | |
| AQDGRLSSNDRVLAI | 376 | Q8N448 | |
| ASLELRGLARVADNA | 501 | Q8TDD1 | |
| RDLEALRLANAQLEG | 801 | Q9P219 | |
| AQAADVLELLLRAGA | 251 | Q15653 | |
| LINIRRGNNIASELE | 361 | P08069 | |
| EQLRALQGRQAALLA | 291 | Q15154 | |
| DVLGDAALQRLRDRQ | 131 | Q8N8D1 | |
| RLQDLRLQDAVLGAA | 161 | Q9BRP1 | |
| LANATDGVRLAARIV | 171 | Q8NDH3 | |
| RLNIIIIAEGAIDRN | 256 | P17858 | |
| AAQRGQELSRLEAAI | 1631 | Q92817 | |
| GLEAERARLAAQLDA | 186 | P54845 | |
| VFVALRGLRNLSEEN | 441 | Q8N2G8 | |
| ARNLLGLIEAKENRN | 81 | P07492 | |
| QFLGADASRVIRNAL | 756 | P55160 | |
| AGERARQLDALLEAL | 1656 | P55268 | |
| LAERKAQGVLAAQAR | 1716 | P55268 | |
| AQGVLAAQARAEQLR | 1721 | P55268 | |
| RNDQIGRAAVLQELA | 256 | Q96KN1 | |
| GRLQAELAAQEALRE | 581 | Q96CN5 | |
| RIENADARNGDLLRT | 2001 | P24043 | |
| LGRLQAAASEEQARR | 76 | Q96KK3 | |
| QRLQATLNVLRDGAA | 111 | Q96N16 | |
| ARRVAAELQAAAAEL | 376 | P03971 | |
| ARSGLRAQDRLIEVN | 186 | Q15599 | |
| LEELLAGLRQRAALD | 441 | Q2VPB7 | |
| AKDAERAINTLNGLR | 71 | Q15717 | |
| TLRRQQLAQDALEGL | 36 | O15287 | |
| AVALIQAGRAQDALT | 401 | O15287 | |
| DAALQQLRAAALISR | 506 | O15287 | |
| AAALRQALQLDGDLQ | 276 | P0C869 | |
| NVSLRVLVGDRNDNA | 541 | Q9Y5G0 | |
| LLAENAAVDVVRARA | 736 | Q0VG06 | |
| VAATLGAILNRLRDN | 386 | P19367 | |
| QLALAQEARVRLQGE | 581 | Q08378 | |
| NAVGILSRRLQEALA | 1001 | Q08378 | |
| LQQRLQGAREDALLD | 541 | O95613 | |
| IRRALEQQPLAAGAA | 1901 | O95613 | |
| AGLSNRLARDNELRE | 511 | P42336 | |
| GLEDLAADRINRLQA | 4781 | Q9UPN3 | |
| AAALQEALENAGRLI | 16 | O75694 | |
| EALENAGRLIDRQLQ | 21 | O75694 | |
| VNGAGLAQRLQRDLA | 326 | Q9BYG4 | |
| RDLAARNILVGENTL | 311 | Q13882 | |
| QRARQLAALIGESEA | 871 | Q01970 | |
| IQLDGLNASQIRELR | 56 | P14625 | |
| RALDAAAGITRNVLQ | 161 | Q96HR9 | |
| AAVAELQAALERQAL | 61 | P27469 | |
| RREQLEAEGQALLLA | 926 | Q5TZA2 | |
| GLSDREAQAQALQDR | 1671 | Q5TZA2 | |
| RLGSLQRALAQLEAE | 1846 | Q5TZA2 | |
| LAQLRAAQLEGERSQ | 416 | O75146 | |
| GAVRQREADLLAAQS | 561 | O75146 | |
| LRKELERVAGALQAQ | 106 | Q0D2H9 | |
| LEQALSFVQALIRGR | 106 | O15303 | |
| GNVEQELRASLAALR | 751 | Q96HP0 | |
| LLQFEGRNRISAEDA | 426 | Q00536 | |
| ERLRAQLTVAQEGLA | 1031 | H7BZ55 | |
| AEAALGLARANNELL | 76 | Q9H972 | |
| ADFIGVVRNNEALAR | 681 | P06756 | |
| LRELQRLAAADGAVA | 76 | Q8NI99 | |
| QRFAQLELSRAGLEQ | 251 | Q96LA8 | |
| QAQALAGAELRTRLE | 186 | A1A5D9 | |
| AQDGRLRVNDSILFV | 106 | P78352 | |
| QLRDNAVEIFLTNGR | 3081 | Q99698 | |
| VRFLLDSGANANVRE | 151 | Q6ZW76 | |
| ERRARLQAEAQELLG | 151 | Q8TAE8 | |
| ALQSDRLARLANEGA | 146 | Q9P2N6 | |
| AQSFAERLRLGIAVI | 196 | O60256 | |
| GDAVVLLRARDLFNL | 196 | Q9H9S5 | |
| LAAEAAARLEAQARV | 321 | O75052 | |
| QAVDRALAEGVLLRT | 21 | P48637 | |
| GESLFIRREQANNIL | 21 | P00742 | |
| LAQRLAQEAALVARG | 901 | Q16099 | |
| RLALALAREQINGII | 41 | Q16478 | |
| LEVARNVALGNAIRI | 251 | Q8TEX9 | |
| EQALGERDQALAQLR | 131 | Q494R4 | |
| AALGNEAAQERLRAL | 416 | Q14154 | |
| GADRIELLIDAARQL | 41 | Q8IU81 | |
| LNETALGALARVLRE | 171 | Q92845 | |
| AATALVRLAQLGAAD | 3946 | P98161 | |
| QRDALQDSLARLEGL | 146 | Q96A99 | |
| VARLTQERGRAQADL | 1006 | Q14980 | |
| RLSDAVKQLQAAERG | 711 | Q16363 | |
| GEAARAAGFNVLRLI | 156 | Q0VDF9 | |
| LVVEVALGNAARALD | 436 | Q96AX9 | |
| DGSLQRARIALVKND | 551 | Q9Y6R4 | |
| VREQEAGLLQFLRLD | 216 | Q9NZL4 | |
| VALREELNALRGENA | 16 | Q5HYW3 | |
| GAARQALADAIIELQ | 2376 | Q5T011 | |
| NGRLAAELEDRRQLA | 241 | Q9NQG5 | |
| LAEQRVERLGSLVAA | 66 | Q7Z6J9 | |
| QQRELQEALGARAAL | 116 | O15061 | |
| ARAALEALLGRLQAE | 126 | O15061 | |
| ALGLEQLRARLEDAL | 241 | O15061 | |
| LAERNAALEQENGLL | 351 | Q9Y3Q8 | |
| LAELRNQSVREFLDG | 166 | P29590 | |
| RLLRDAEGLQELALA | 81 | Q9H469 | |
| GRALRDAAENLFQEL | 11 | C9JCN9 | |
| QAVQGLREGRLAAVD | 256 | P58107 | |
| SGRLARVENALNNLD | 1506 | Q13796 | |
| SARLQRELEAQRAGF | 521 | Q9UL54 | |
| GVANEDSRRLAAILN | 2541 | Q9UKZ4 | |
| EEAAGQLRRELRQAA | 81 | Q9HBH5 | |
| VGIDAAIANAFRRIL | 66 | O15160 | |
| RRDLAQALINRGVNL | 321 | P46087 | |
| QQRGAAEALLFRLQT | 361 | Q9NRC6 | |
| GRFQALAEIADILRQ | 481 | Q9NRC6 | |
| RQAEALLGQAQAFVR | 2841 | Q9NRC6 | |
| FELRELQAELRQNGL | 1776 | Q8IY92 | |
| LGTQVRQLQEDAARL | 1856 | Q01082 | |
| AFQNELGIAALRRVL | 566 | Q66K14 | |
| IRDLNFEVRSGANVL | 456 | P28288 | |
| VRLLLNNDNLLREGA | 36 | P47755 | |
| LRNAAGDTRDAVQAL | 146 | Q9Y240 | |
| RFQAVVALAVGRLAD | 401 | Q15021 | |
| ILERLQTDGQFALAR | 1676 | Q96JI7 | |
| QTDGQFALARRVAEL | 1681 | Q96JI7 | |
| EAGQRLRRLQDQLAA | 26 | Q8NFZ5 | |
| QALRAFLVEQEGRLL | 221 | Q9C029 | |
| QERQLRAAALALGAA | 186 | A2A3L6 | |
| NLDIRRAIQILNEGA | 531 | Q9NXC5 | |
| ALESELQQLRARLQG | 326 | Q96AQ6 | |
| ELQARAGERARALEA | 836 | O15020 | |
| IAARVGELTREANAL | 1011 | O15020 | |
| IDSLAAVVLQNRRGL | 406 | P60508 | |
| AVAFLERNNREILAG | 111 | O60499 | |
| AGNALASLALEVQAR | 66 | Q86SX3 | |
| RQSEARLQALQEAGL | 341 | Q969T3 | |
| ARGRALNIVDQEGSL | 211 | Q8IX01 | |
| QDKLAQIRDARGALS | 471 | O14964 | |
| ERGAAIQLAEGLARQ | 41 | Q96FA7 | |
| LRVRFADALGLELAQ | 101 | O95685 | |
| AQSERVEALNAAALR | 586 | Q9H254 | |
| QQVSLAEGDRFLLLR | 41 | Q9BRR9 | |
| LGIANNRLIRIDLAV | 571 | Q86UX7 | |
| RQGQEALARLQAALA | 111 | Q15814 | |
| EAAAGRLQRLRDANE | 1571 | P11277 | |
| QEAARRAQAEQAALR | 2281 | Q15149 | |
| SVAAQEAARLRQLAE | 2421 | Q15149 | |
| RQLAEEDLAQQRALA | 2431 | Q15149 | |
| ERLAILDSQAGQIRA | 846 | Q86UU1 | |
| AELVALAQAVNARAL | 356 | P22314 | |
| ALLNQRRDQSIVALG | 646 | Q8IUG5 | |
| QLQALANLEARRGSI | 561 | A8K0R7 | |
| ELLDNLSGADVRQNR | 716 | Q8N9V7 | |
| AASVVRDNEQLALRG | 891 | Q8N398 | |
| RPDNRAGAEELQALL | 41 | Q6ZT12 | |
| QRLREAAEGLRVATN | 891 | Q9Y4G6 | |
| RLEQLDVRLNALAGL | 196 | P0DKB5 | |
| GLLQILLEQARARAA | 81 | Q96RP3 | |
| EGATLLVAVNELRRN | 356 | Q6PML9 | |
| RRLARFDVILVQGNE | 271 | Q6R2W3 | |
| RNNGILEIEAARILI | 526 | Q5TAH2 | |
| RFDQARGVLELASAQ | 256 | Q86VR7 | |
| DLRQLQRVEEALGAA | 161 | O60294 | |
| LNFGLAREQARAEGI | 116 | Q3LXA3 | |
| DEVLGLARALVAQGR | 526 | Q5TAA0 | |
| ERRNLDRQAGLAVVL | 1176 | Q5VUA4 | |
| REAEQRAALARLAGQ | 71 | P53814 | |
| LAEGLRNENLSAVAR | 21 | Q86WV1 | |
| RDIRSIQEALARNAG | 471 | Q8N5A5 | |
| NRRANALLANGVELR | 106 | P01375 | |
| GARQQLEERFADLAA | 56 | Q2TAM9 | |
| LQDVLGRQRAAIEGQ | 1996 | Q5THJ4 | |
| LRKELERVAGALQAQ | 311 | A6NC78 | |
| ALLQAQLRGQDAARR | 36 | Q69YL0 | |
| QLRGQDAARRLQDLA | 41 | Q69YL0 |